UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q


 

(Mark one)

☒         QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2020March 31, 2021

 

or

 

☐         TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period fromto                         to.

 

Commission File Number: 000-24248


lrad20210331_10qimg001.gif

GENASYS INC.

(Exact name of registrant as specified in its charter)


Delaware

87-0361799

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification Number)

  

1626216262 West Bernardo Drive,, San Diego,

California

92127

(Address of principal executive offices)

(Zip Code)

 

(858) 676-1112

(Registrant’sRegistrants telephone number, including area code)


 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which securities are registered

Common stock, $0.00001 par value per share

GNSS

NASDAQ Capital Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    ☒   Yes     ☐  No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    ☒  Yes    ☐  No

 


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

    

Non-accelerated filer

Smaller reporting company

    

Emerging growth company

  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    ☐  Yes  ☒    No

 

The number of shares of Common Stock, $0.00001 par value, outstanding on August 7, 2020May 11, 2021 was 33,490,544.

33,849,566.



 

 

 

PART I. FINANCIAL INFORMATION

 

Item 1.

Financial Statements

Item1.Financial Statements

 

Genasys Inc.

 

Genasys Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except par value and share amounts)

 

 

June 30,

      

March 31,

     
 

2020

  

September 30,

  

2021

  

September 30,

 
 

(Unaudited)

  

2019

  

(Unaudited)

  

2020

 

ASSETS

                

Current assets:

                

Cash and cash equivalents

 $20,667,934  $18,819,078  $18,455  $23,319 

Short-term marketable securities

  4,054,126   3,695,364   5,474   4,265 

Restricted cash

  270,604   263,136   282   282 

Accounts receivable, net

  6,378,357   3,644,059   5,445   5,442 

Inventories, net

  7,334,165   5,835,163   6,451   5,949 

Prepaid expenses and other

  1,052,750   1,781,837   1,082   860 

Total current assets

  39,757,936   34,038,637   37,189   40,117 
                

Long-term marketable securities

  3,336,654   1,384,819   2,450   3,805 

Long-term restricted cash

  395,321   434,704   1,190   395 

Deferred tax assets, net

  4,644,510   5,387,000   10,817   11,095 

Property and equipment, net

  1,984,667   2,269,506   1,901   1,930 

Goodwill

  2,371,190   2,305,750   8,380   2,472 

Intangible assets, net

  981,186   1,175,634   3,570   943 

Operating lease right of use asset

  5,428,168   -   5,216   5,285 

Other assets

  124,412   123,933   195   125 

Total assets

 $59,024,044  $47,119,983  $70,908  $66,167 
                

LIABILITIES AND STOCKHOLDERS' EQUITY

                

Current liabilities:

                

Accounts payable

 $2,907,077  $859,530  $2,555  $1,370 

Accrued liabilities

  8,883,114   8,134,341   6,994   7,880 

Notes payable, current portion

  287,523   279,588   300   300 

Operating lease liabilities, current portion

  752,371   -   859   771 

Total current liabilities

  12,830,085   9,273,459   10,708   10,321 
                

Notes payable, less current portion

  16,919   32,903   -   18 

Other liabilities, noncurrent

  383,413   2,432,272   884   293 

Operating lease liabilities, noncurrent

  6,586,196   -   6,172   6,395 

Total liabilities

  19,816,613   11,738,634   17,764   17,027 
                

Stockholders' equity:

                

Preferred stock, $0.00001 par value; 5,000,000 shares authorized; none issued and outstanding

  -   -   -   - 

Common stock, $0.00001 par value; 50,000,000 shares authorized; 33,490,544 and 32,949,987 shares issued and outstanding, respectively

  335   330 

Common stock, $0.00001 par value; 100,000,000 shares authorized; 33,849,566 and 33,561,544 shares issued and outstanding, respectively

  -   - 

Additional paid-in capital

  90,904,503   89,571,641   95,218   91,248 

Accumulated deficit

  (51,305,924)  (53,731,903)  (42,215)  (41,858)

Accumulated other comprehensive loss

  (391,483)  (458,719)

Accumulated other comprehensive income (loss)

  141   (250)

Total stockholders' equity

  39,207,431   35,381,349   53,144   49,140 

Total liabilities and stockholders' equity

 $59,024,044  $47,119,983  $70,908  $66,167 

 

See accompanying notes

 

1

 

Genasys Inc.

 

Genasys Inc.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts)

(Unaudited)

 

 

Three months ended

  

Nine months ended

  

Three months ended

  

Six months ended

 
 

June 30,

  

June 30,

  

March 31,

  

March 31,

 
 

2020

  

2019

  

2020

  

2019

  

2021

  

2020

  

2021

  

2020

 

Revenues:

                                

Product sales

 $10,932,719  $8,037,460   26,494,138   26,726,151  $10,131  $7,553  $17,081  $15,561 

Contract and other

  1,038,377   826,266   2,535,433   2,506,825   1,170   723   2,248   1,497 

Total revenues

  11,971,096   8,863,726   29,029,571   29,232,976   11,301   8,276   19,329   17,058 

Cost of revenues

  5,499,914   4,261,733   13,946,392   14,351,217   5,964   4,266   10,288   8,446 
                                

Gross Profit

  6,471,182   4,601,993   15,083,179   14,881,759   5,337   4,010   9,041   8,612 
                                

Operating expenses

                                

Selling, general and administrative

  3,330,365   2,712,846   8,884,230   7,939,232   3,824   2,732   7,155   5,554 

Research and development

  1,199,635   1,202,686   3,232,369   3,530,805   960   949   2,026   2,033 

Total operating expenses

  4,530,000   3,915,532   12,116,599   11,470,037   4,784   3,681   9,181   7,587 
                                

Income from operations

  1,941,182   686,461   2,966,580   3,411,722 

Income (loss) from operations

  553   329   (140)  1,025 
                                

Other income

  36,227   69,890   201,889   126,566 

Other income (expense), net

  (8)  70   61   166 
                                

Income before income taxes

  1,977,409   756,351   3,168,469   3,538,288 

Income (loss) before income taxes

  545   399   (79)  1,191 

Income tax expense

  473,332   118,310   742,490   675,457   283   97   278   269 

Net income

 $1,504,077  $638,041  $2,425,979  $2,862,831 

Net income (loss)

 $262  $302  $(357) $922 
                                

Net income per common share:

                

Basic

 $0.05  $0.02  $0.07  $0.09 

Diluted

 $0.04  $0.02  $0.07  $0.09 

Net income (loss) per common share - basic and diluted

 $0.01  $0.01  $(0.01) $0.03 

Weighted average common shares outstanding:

                                

Basic

  33,289,426   32,575,118   33,122,042   32,684,311   33,683,240   33,094,596   33,629,479   33,036,786 

Diluted

  34,280,915   33,372,777   33,878,243   33,341,057   34,779,266   33,732,619   33,629,479   33,708,832 

 

See accompanying notes

 

2

 

Genasys Inc.

 

Genasys Inc.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME

(in thousands)

(Unaudited)

 

 

Three months ended

  

Nine months ended

  

Three months ended

  

Six months ended

 
 

June 30,

  

June 30,

  

March 31,

  

March 31,

 
 

2020

  

2019

  

2020

  

2019

  

2021

  

2020

  

2021

  

2020

 

Net income

 $1,504,077  $638,041  $2,425,979  $2,862,831 

Net income (loss)

 $262  $302  $(357) $922 

Other comprehensive income

                                

Unrealized gain (loss) on marketable securities

  8,114   9,483   (3,064)  19,102 

Unrealized (loss) on marketable securities

  (3)  (8)  (6)  (11)

Unrealized foreign currency gain (loss)

  43,160   47,055   70,300   (85,990)  (75)  (62)  397   27 

Comprehensive income

 $1,555,351  $694,579  $2,493,215  $2,795,943  $184  $232  $34  $938 

 

3

 

 

Genasys Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(Unaudited)

 

 

Nine months ended

  

Six months ended

 
 

June 30,

  

March 31,

 
 

2020

  

2019

  

2021

  

2020

 

Operating Activities:

                

Net income

 $2,425,979  $2,862,831 

Net (loss) income

 $(357) $922 
                

Adjustments to reconcile net income to net cash provided by operating activities:

        

Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:

Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:

     

Depreciation and amortization

  620,060   623,317   552   415 

Amortization of debt issuance costs

  2   - 

Warranty provision

  2,396   62,689   37   (11)

Inventory obsolescence

  168,262   121,035   196   128 

Share-based compensation

  775,642   563,386   510   454 

Realized loss on foreign currency forward contract

  (48)  - 

Unrealized loss on foreign currency forward contract

  (28)  - 

Deferred income taxes

  742,490   675,457   278   269 

Amortization of operating lease right of use asset

  445,692   -   343   292 

Accretion of acquisition holdback liability

  22   - 
        

Changes in operating assets and liabilities:

                

Accounts receivable, net

  (2,721,719)  (4,029,608)  (14)  (2,205)

Inventories, net

  (1,667,264)  200,306   (698)  (1,214)

Prepaid expenses and other

  731,501   2,447,870   (253)  787 

Accounts payable

  2,039,811   (2,267,016)  1,184   1,072 

Accrued and other liabilities

  147,740   1,153,067   (1,363)  (3,036)

Net cash provided by operating activities

  3,710,590   2,413,334 

Net cash provided by (used in) operating activities

  363   (2,127)
                

Investing Activities:

                

Purchases of marketable securities

  (5,496,651)  (3,290,667)  (2,799)  (2,013)

Proceeds from maturities of marketable securities

  3,182,989   3,624,338   2,939   1,971 

Cash paid for Amika Mobile

  (4,367)  - 

Capital expenditures

  (111,602)  (303,912)  (148)  (102)

Net cash (used in) provided by investing activities

  (2,425,264)  29,759 

Net cash used in investing activities

  (4,375)  (144)
                

Financing Activities:

                

Proceeds from exercise of stock options

  996,891   54,621   170   258 

Repurchase of common stock

  (398,256)  (2,171,022)  -   (398)

Shares retained for payment of taxes in connection with settlement of restricted stock units

  (41,410)  -   (141)  (41)

Payments on promissory notes

  (16,700)  (17,044)  (18)  (17)

Net cash provided by (used in) financing activities

  540,525   (2,133,445)

Cash paid for debt issuance costs

  (38)  - 

Net cash used in financing activities

  (27)  (198)

Effect of foreign exchange rate on cash

  (8,910)  (21,443)  (30)  11 

Net increase in cash, cash equivalents, and restricted cash

  1,816,941   288,205 

Net decrease in cash, cash equivalents, and restricted cash

  (4,069)  (2,458)

Cash, cash equivalents and restricted cash, beginning of period

  19,516,918   11,806,074   23,996   19,517 

Cash, cash equivalents and restricted cash, end of period

 $21,333,859  $12,094,279  $19,927  $17,059 
         

Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets:

                

Cash and cash equivalents

 $20,667,934  $11,290,068  $18,455  $16,399 

Restricted cash, current portion

  270,604   369,551   282   265 

Long-term restricted cash

  395,321   434,660   1,190   395 

Total cash, cash equivalents and restricted cash shown in the consolidated statement of cash flows

 $21,333,859  $12,094,279  $19,927  $17,059 

 

See accompanying notes

 

4

 

Genasys Inc.-

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)

(in thousands)

(Unaudited)

 

 

Nine months ended June 30,

  

Six months ended March 31,

 
 

2020

  

2019

 

Supplemental disclosures of cash flow information:

        

Interest paid

 $-  $2,860 
         

2021

  

2020

 

Noncash investing and financing activities:

                

Change in unrealized gain (loss) on marketable securities

 $(3,064) $19,102  $(6) $(11)

Initial measurement of operating lease ROU assets

 $5,823,972  $- 

Obligation to issue common stock in connection with the purchase of Amika Mobile

 $(3,431) $- 

Initial measurement of operating lease right of use assets

 $259  $5,824 

Initial measurement of operating lease liabilities

 $7,814,701  $-  $259  $7,815 
        

Business combination accounted for as a purchase

        

Fair value of asset purchase holdback liability

 $613  $- 

 

5

(in thousands, except per share and share amounts)

(Unaudited)

 

 

1. OPERATIONS

 

Genasys Inc. (formerly LRAD®LRAD® Corporation), a Delaware corporation (the “Company”), is engaged in the design, development and commercialization of directed and multidirectional sound technologies, voice broadcast products, and location-based mass messaging solutions for emergency warning and workforce management. The principal markets for the Company’s proprietary sound reproduction technologies, voice broadcast products and mass messaging solutions are in North and South America, Europe, the Middle East and Asia. On October 23, 2019, the Company announced its rebranding and began doing business as Genasys Inc.

 

 

2. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

 

General

 

The Company’s unaudited interim condensed consolidated financial statements included herein have been prepared in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X and the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. In management’s opinion, the accompanying financial statements reflect adjustments necessary to present fairly the financial position, results of operations, and cash flows for those periods indicated, and contain adequate disclosure to make the information presented not misleading. Adjustments included herein are of a normal, recurring nature unless otherwise disclosed in the footnotes. The condensed consolidated financial statements and notes thereto should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended September 30, 20192020 included in the Company’s Annual Report on Form 10-K, as filed with the SEC on December 10, 2019.2020. The accompanying condensed consolidated balance sheet at September 30, 20192020 has been derived from the audited consolidated balance sheet at September 30, 20192020 contained in the above referenced Form 10-K. Results of operations for interim periods are not necessarily indicative of the results of operations for a full year.

 

Principles of Consolidation

 

The Company has threeseven wholly owned subsidiaries, Genasys II Spain, S.A.U.S.A.U (“Genasys Spain”), Genasys Communications Canada ULC, Genasys Singapore PTE Ltd, Genasys Puerto Rico, LLC and Genasys Inc. (branch) in the United Arab Emirates and two currently inactive subsidiaries, Genasys America de CV and LRAD International Corporation. The condensed consolidated financial statements include the accounts of these subsidiaries after elimination of intercompany transactions and accounts.

 

Cash, cash equivalents and restricted cash

The Company considers all highly liquid investments with an original maturity of three months or less, when purchased, to be cash equivalents. As of March 31, 2021, the amount of cash and cash equivalents was $18,455. As of September 30, 2020, the amount of cash and cash equivalents was $23,319.

The Company considers any amounts pledged as collateral or otherwise restricted for use in current operations to be restricted cash. In addition, the Company excludes from cash and cash equivalents cash required to fund specific future contractual obligations related to business combinations. Restricted cash is classified as a current asset unless amounts are not expected to be released and available for use in operations within one year. As of March 31, 2021, the current portion of restricted cash was $282 and the noncurrent portion was $1,190. As of September 30, 2020, the current portion of restricted cash was $282 and the noncurrent portion was $395.

Immaterial Correction of Prior Period Financial Statements

During the quarter ended December 31, 2020, Company management identified an immaterial error in the previously issued September 30, 2020 consolidated balance sheet. This error resulted in an overstatement of prepaid expenses and accrued liabilities of $5,205 related to a foreign currency forward contract which was presented on a gross basis rather than on a net basis. There was no impact to the consolidated statement of operations or the consolidated statement of cash flows as of September 30, 2020, as a result of this misstatement. Further, there was no impact to the condensed consolidated financial statements as of, and for the six months ended March 31, 2021, as the forward contract was settled during the first quarter of fiscal 2021.  SEC Staff Accounting Bulletin: No. 99 – Materiality and No. 108 – Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements were used by management to evaluate the impact of the misstatement. Management concluded that this misstatement had no material impact on either the accompanying condensed consolidated balance sheet as of March 31, 2021 or the previously issued consolidated balance sheet as of September 30, 2020, and therefore the misstatement was corrected in the accompanying condensed consolidated balance sheet as of September 30, 2020. All financial information contained in the accompanying notes to these condensed consolidated financial statements has been revised to reflect the correction of this error.

Reclassifications

 

Where necessary, the prior year’s information has been reclassified to conform to the current year presentation.

6

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

 

3. RECENT ACCOUNTING PRONOUNCEMENTS

 

New pronouncements pending adoption

 

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, Measurement of Credit Losses on Financial Instruments, which supersedes current guidance by requiring recognition of credit losses when it is probable that a loss has been incurred. The new standard requires the establishment of an allowance for estimated credit losses on financial assets, including trade and other receivables at each reporting date. The new standard will result in earlier recognition of allowances for losses on trade and other receivables and other contractual rights to receive cash. In November 2019, the FASB issued ASU No. 2019-10, Financial Instruments Credit Losses (Topic 326), Derivatives and Hedging (Topic 815) and Leases (Topic 842), which extends the effective date of Topic 326 for certain companies until fiscal years beginning after December 15, 2022. The new standard will be effective for the Company in the first quarter of its fiscal year beginning October 1, 2023, and early adoption is permitted. The Company has not completed its review of the impact of this standard on its consolidated financial statements. However, based on the Company’s history of immaterial credit losses from trade receivables, management does not expect that the adoption of this standard will have a material effect on the Company’s consolidated financial statements.

 

New pronouncements adopted

In May 2014,March 2020, the FASB issued ASU No. 2014-09,2020-04, Revenue from Contracts with Customers (“ASU 2014-09”)Reference Rate Reform (Topic 848), which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. ASU 2014-09 replaced most existing revenue recognition guidance in U.S. generally accepted accounting principles. In July 2015, the FASB deferred the effective dateFacilitation of the standard by an additional year; however, it provided companies the option to adopt one year earlier, commensurate with the original effective date. Accordingly, the standard was effective for the Company in the fiscal year beginning October 1, 2018. Subsequently the FASB has issued additional guidance (ASUs 2015-14; 2016-08; 2016-10; 2016-12; 2016-13; 2016-20). The adoptionEffects of this guidance by the Company, effective October 1, 2018, did not have a material impactReference Rate Reform on the Company’s consolidated financial statements (see Note 4, Revenue Recognition, for further detail)Financial Reporting. ASU No. 2014-092020-04 provides optional guidance, expedients and its amendments form Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (“Topic 606”).

6

In February 2018,exceptions for a limited period of time to ease the FASB issued ASU No. 2018-02, Income Statement—Reporting Comprehensive Income (Topic 220). The amendmentspotential burden in this ASU allow a reclassification from accumulated other comprehensive income to retained earningsaccounting for stranded tax(or recognizing the effects resulting from the Tax Cuts and Jobs Act. Consequently, the amendments eliminate the stranded tax effects resulting from the Tax Cuts and Jobs Act and will improve the usefulness of information reported toof) reference rate reform on financial statement users. However, because the amendments only relate to the reclassification of the income tax effects of the Tax Cuts and Jobs Act, the underlying guidance that requires that the effect of a change in tax laws or rates be included in income from continuing operations is not affected.reporting. The amendments in this update also requireapply to all entities, subject to meeting the criteria, which participate in contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. ASU No. 2020-04 was subsequently amended by ASU No. 2021-01, Reference Rate Reform (Topic848), Scope, which refines the scope of Topic 848 and permits optional expedients and exceptions when accounting for derivative contracts and certain disclosures about stranded tax effects.hedging relationships. The guidance was effective for fiscal years beginning afteramendments of these updates are available to all entities as of March 12, 2020 through December 15, 2018 with early adoption permitted, including interim periods within31, 2022. The Company has not yet adopted these amendments. The Company’s management does not expect that fiscal year. Accordingly, this was effective for the Company beginning October 1, 2019. The adoption of this ASU did notstandard will have an impacta material effect on the Company’s consolidated financial statements.

 

New pronouncements adopted

In February 2016,August 2018, the FASB issued ASU No. 2016-02, 2018Leases (-13, Topic 842)Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, which issued new guidance relatedimproves fair value disclosure requirements by removing disclosures that are not cost beneficial, clarifying disclosures’ specific requirements and adding relevant disclosure requirements. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to leases that outlines a comprehensive lease accounting modeldevelop Level 3 fair value measurements, and supersedes the current lease guidance.narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The new guidance requires lessees to recognize lease liabilities and corresponding right-of-use assetsis effective for all leases with lease terms of greater than 12 months. Leases with a term of 12 months or less will be accountedentities for in a manner similar to the guidance for operating leases prior to the adoption of Topic 842. Topic 842 requires entities to recognizefiscal years beginning after December 15, 2019, and measure leases existing at, or entered into after, the beginning of the earliest comparative period presented using a modified retrospective approach, with certain practical expedients available. In July 2018, the FASB issued ASU No. 2018-11, which offers a practical expedient that allows entities the option to apply the provisions of Topic 842 by recognizing a cumulative effect adjustment at the effective date of adoption without adjusting the prior comparative periods presented. In March 2019, the FASB issued ASU 2019-01, which explicitly provides disclosure relief for interim periods during the year the standard is adopted.

The new guidance was effective for the Company beginning October 1, 2019.within those fiscal years. The Company adopted Topic 842 by applying the modified retrospective transition approach. Under this method, financial information related to periods prior to adoption will be as originally reported under the then-current standard (Topic 840, Leases). The Company elected the following practical expedients:

The transitional practical expedients, which must be elected as a package and applied consistently to all leases. In electing this practical expedient package, the Company is not required to:

 o

reassess whether an existing or expired contract is or contains a lease;

 o

reassess the lease classification for any expired or existing leases; and

 o

reassess initial direct lease costs for all leases that commenced before the adoption.

Short-term lease practical expedient in which the Company can elect not to apply the recognition requirements of Topic 842 to short-term leases.

As a result of adopting Topic 842 effectiveASU No. 2018-13 on October 1, 2019, the Company recorded an initial measurement of $7,814,701 of operating lease liabilities and $5,823,972 of corresponding operating Right of Use (“ROU”) assets, net of tenant improvement allowances and deferred rent, primarily related2020, with no impact to the Company’s facility lease. There was no other impact from the adoption of Topic 842. A portion of the existing leases are denominated in currencies other than the U.S. dollar. As a result, the associated lease liabilities will be remeasured using the current exchange rate in the applicable reporting periods, which may result in foreign exchange gains or losses. There was no cumulative effect adjustment to retained earnings as a result of the transition to Topic 842. See Note 12, Leases for further disclosures related to Topic 842.condensed consolidated financial statements.

 

 

4.

BUSINESS COMBINATION

On October 2, 2020, the Company completed the purchase of the assets of Amika Mobile Corporation (“Amika Mobile”) pursuant to an Asset Purchase Agreement. Amika Mobile is a leading provider of integrated emergency critical communications based in Ottawa, Canada. The Company believes the Amika Mobile asset purchase will expand the Company’s enterprise software solutions and enhance the Company’s unified multi-channel critical communications platform.

The Amika Mobile asset purchase was accounted for as a business combination using the acquisition method pursuant to ASC Topic 805. As the acquirer for accounting purposes, the Company has estimated the purchase consideration, assets acquired and liabilities assumed as of the acquisition date, with the excess of the purchase consideration over the fair value of net assets acquired recognized as goodwill. The estimated fair value of assets purchased and liabilities assumed in certain cases may be subject to revision based on the final determination of fair value.

The consideration consisted of the following:

Cash paid

 $4,367 

Asset purchase holdback liability

  613 

Common stock to be issued

  3,431 
  $8,411 

7

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

Under the terms of the Asset Purchase Agreement, the Company is required to deposit a holdback liability in the amount of CAD$1,000 into an interest-bearing account as security for potential indemnification claims against the seller. The holdback amount will be released three years from the closing date subject to amounts withheld for actual, pending or potential claims. The Company also agreed to issue 191,267 shares of the Company’s common stock to the seller of the Amika Mobile assets on each of the first, second and third anniversaries of the closing date. The total number of shares of common stock the Company is obligated to issue is 573,801. The fair value of the Company’s common stock on the closing date was $5.98, resulting in an addition of $3,431 to additional paid-in-capital. The cash portion of the purchase price was funded from cash on hand.

The Company incurred $264 in expenses related to this transaction through March 31, 2021. These expenses were recorded in selling, general and administrative expenses in the condensed consolidated statement of operations as follows: $22 in the second quarter of fiscal 2021, $10 in the first quarter of fiscal 2021, $132 in the fourth quarter of fiscal 2020 and $100 in the third quarter of fiscal 2020.

Purchase Price Allocation

Assets Acquired

    

Prepaid expenses

 $2 

Fixed assets

  22 

Operating lease right of use asset

  248 

Intangible Assets

  2,820 

Goodwill

  5,590 

Total assets acquired

 $8,682 
     

Liabilities assumed

    

Accrued liabilities

 $23 

Operating lease liability

  248 

Total liabilities assumed

  271 

Net Assets acquired

 $8,411 

The estimated fair value of the identifiable intangible assets acquired and their estimated useful lives are as follows:

  

Fair Value

  

Useful Lives (in years)

 

Developed technology

 $2,500   7 

Customer relationships

  320   7 
  $2,820     

Identifiable intangible assets consist of certain technology and customer relationships purchased from Amika Mobile. Identifiable intangible assets are amortized over their useful lives based upon a number of assumptions, including the estimated period of economic benefit and utilization. The weighted average amortization period for identifiable intangible assets acquired is 7 years. These intangible assets are classified as Level 3 in the ASC topic 820 three-tier fair value hierarchy.

The goodwill for Amika Mobile is attributable to combining the Company’s existing emergency communications solutions with the software and software development capabilities of Amika Mobile to enhance product offerings. Goodwill is also attributable to the skill level of the acquired workforce. The Company will continue to analyze the transaction and refine its calculations, as appropriate during the measurement period, which could affect the value of goodwill. Goodwill from the Amika Mobile asset purchase will not be deductible for tax purposes.

5.

REVENUE RECOGNITIONRECOGNITON

 

The Company adopted the guidance in Topic 606 on October 1, 2018. The Company adopted the new standard using the full retrospective approach.

 

Topic 606 outlines a new, single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most revenue recognition guidance, including industry-specific guidance. This new revenue recognition model provides a five-step analysis in determining when and how revenue is recognized:

 

 

1.

Identify the contract(s) with customers

 

2.

Identify the performance obligations

8

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

3.

Determine the transaction price

 

4.

Allocate the transaction price to the performance obligations

 

5.

Recognize revenue when the performance obligations have been satisfied

 

Topic 606 requires revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration a company expects to receive in exchange for those goods or services.

 

The Company derives its revenue from the sale of products to customers, contracts, license fees, other services and freight. The Company sells its products through its direct sales force and through authorized resellers and system integrators. The Company recognizes revenue for goods including software when all the significant risks and rewards have been transferred to the customer, no continuing managerial involvement usually associated with ownership of the goods is retained, no effective control over the goods sold is retained, the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transactions will flow to the Company, and the costs incurred or to be incurred in respect of the transaction can be measured reliably. Software license revenue, maintenance and/or software development service fees may be bundled in one arrangement or may be sold separately.

7

 

Product Revenue

 

Product revenue is recognized as a distinct single performance obligation when products are tendered to a carrier for delivery, which represents the point in time that the Company’s customer obtains control of the products. A smaller portion of product revenue is recognized when the customer receives delivery of the products. A portion of products are sold through resellers and system integrators based on firm commitments from an end user, and as a result, resellers and system integrators carry little or no inventory. The Company’s customers do not have a right to return product unless the product is found defective and therefore the Company’s estimate for returns has historically been insignificant

 

Perpetual licensed software

 

The sale and/or license of software products is deemed to have occurred when a customer either has taken possession of, or has the ability to take immediate possession of, the software and the software key. Perpetual software licenses can include one-year maintenance and support services. In addition, the Company sells maintenance services on a stand-alone basis and is therefore capable of determining their fair value. On this basis, the amount of the embedded maintenance is separated from the fee for the perpetual license and is recognized on a straight-line basis over the period to which the maintenance relates.

 

Time-based licensed software

 

The time-based license agreements include the use of a software license for a fixed term, generally one-year, and maintenance and support services during the same period. The Company does not sell time-based licenses without maintenance and support services and therefore revenues for the entire arrangements are recognized on a straight-line basis over the term.

 

Warranty, maintenance and services

 

The Company offers extended warranty, maintenance and other services. Extended warranty and maintenance contracts are offered with terms ranging from one to several years, which provide repair and maintenance services after expiration of the original one-year warranty term. Revenues from separately priced extended warranty and maintenance contracts are recognized based on time elapsed over the service period and classified as contract and other revenues. Revenue from other services such as training or installation is recognized when the service is completed.

 

Multiple element arrangements

 

The Company has entered into a number of multiple element arrangements, such as the sale of a product or perpetual licenses that may include maintenance and support (included in the price of perpetual licenses) and time-based licenses (that include embedded maintenance and support, both of which may be sold with software development services, training, and other product sales). In some cases, the Company delivers software development services bundled with the sale of the software. In multiple element arrangements, the Company uses either the stand-alone selling price or an expected cost-pluscost plus margin approach to determine the fair value of each element within the arrangement, including software and software-related services such as maintenance and support. In general, elements in such arrangements are also sold on a stand-alone basis and stand-alone selling prices are available.

 

Revenue is allocated to each deliverable based on the fair valuerelative stand-alone selling price of each individual element and is recognized when the revenue recognition criteria described above are met, except for time-based licenses which are not unbundled. When software development services are performed and are considered essential to the functionality of the software, the Company recognizes revenue from the software development services on a stage of completion basis, and the revenue from the software when the related development services have been completed.

 

9

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

The Company disaggregates revenue by reporting segment (Hardware and Software) and geographically to depict the nature of revenue in a manner consistent with the Company’s business operations and to be consistent with other communications and public filings. Refer to Note 18,19, Segment Information and Note 19,20, Major Customers, Suppliers and Related Information for additional details of revenues by reporting segment and disaggregation of revenue.

 

Contract Assets and Liabilities

 

The Company enters into contracts to sell products and provide services and recognizes contract assets and liabilities that arise from these transactions. The Company recognizes revenue and corresponding accounts receivable according to Topic 606 and, at times, recognizes revenue in advance of the time when contracts give the Company the right to invoice a customer. The Company may also receive consideration, per terms of a contract, from customers prior to transferring goods to the customer. The Company records customer deposits as a contract liability. Additionally, the Company may receive payments, most typically for service and warranty contracts, at the onset of the contract and before the services have been performed. In such instances, a deferred revenue liability is recorded. The Company recognizes these contract liabilities as revenue after all revenue recognition criteria are met. The table below shows the balance of contract assets and liabilities as of June 30, 2020March 31, 2021 and September 30, 2019,2020, including the change between the periods. There were no contract assets as of June 30, 2020 and September 30, 2019. The current portion of contract liabilities and the non-current portion are included in “Accrued liabilities” and “Other liabilities, noncurrent”, respectively, on the accompanying Condensed Consolidated Balance Sheets. Refer to Note 10,11, Accrued Liabilities for additional details.

8

 

The Company’s contract liabilities were as follows:

 

 

Customer

deposits

  

Deferred

revenue

  

Total contract

liabilities

  

Customer

deposits

  

Deferred

revenue

  

Total contract

liabilities

 

Balance at September 30, 2019

 $5,063,091  $1,059,407  $6,122,498 

Balance at September 30, 2020

 $3,683  $1,024  $4,707 

New performance obligations

  6,469,112   546,285   7,015,397   5,065   584   5,649 

Recognition of revenue as a result of satisfying performance obligations

  (5,765,395)  (701,741)  (6,467,136)  (5,579)  (785)  (6,364)

Effect of exchange rate on deferred revenue

  -   11,132   11,132   -   11   11 

Balance at June 30, 2020

 $5,766,808  $915,083  $6,681,891 

Balance at March 31, 2021

 $3,169  $834  $4,003 

Less: non-current portion

  -   (383,413)  (383,413)  -   (214)  (214)

Current portion at June 30, 2020

 $5,766,808  $531,670  $6,298,478 

Current portion at March 31, 2021

 $3,169  $620  $3,789 

 

Remaining Performance Obligations

 

Remaining performance obligations related to Topic 606 represent the aggregate transaction price allocated to performance obligations under an original contract with a term greater than one year, which are fully or partially unsatisfied at the end of the period.

 

As of June 30, 2020,March 31, 2021, the aggregate amount of the transaction price allocated to remaining performance obligations was approximately $6,681,891.$4,003. The Company expects to recognize revenue on approximately $6,298,478$3,789 or 94%95% of the remaining performance obligations over the next 12 months, and the remainder is expected to be recognized thereafter.

 

Practical Expedients

 

In cases where the Company is responsible for shipping after the customer has obtained control of the goods, the Company has elected to treat these activities as fulfillment activities rather than as a separate performance obligation. Additionally, the Company has elected to capitalize the cost to obtain a contract only if the period of amortization would be longer than one year. The Company only gives consideration to whether a customer agreement has a financing component if the period of time between transfer of goods and services and customer payment is greater than one year. The Company also utilizes the “as invoiced” practical expedient in certain cases where performance obligations are satisfied over time and the invoiced amount corresponds directly with the value the Company is providing to the customer.

 

 

5.6.

FAIR VALUE MEASUREMENTS

 

The Company’s financial instruments consist principally of cash equivalents, short and long-term marketable securities, accounts receivable accounts payable and notesaccounts payable. The fair value of a financial instrument is the amount that would be received in an asset sale or paid to transfer a liability in an orderly transaction between unaffiliated market participants. Assets and liabilities measured at fair value are categorized based on whether or not the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial instruments within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three levels (with Level 3 being the lowest) defined as follows:

 

Level 1:     
Level 1:Inputs are based on quoted market prices for identical assets or liabilities in active markets at the measurement date.

10

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

Level 2:     Inputs include quoted prices for similar assets or liabilities in active markets and/or quoted prices for identical or similar assets or liabilities in markets that are not active near the measurement date.

Level 3:     Inputs include management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The inputs are unobservable in the market and significant to the instrument’s valuation.

Level 2: Inputs include quoted prices for similar assets or liabilities in active markets and/or quoted prices for identical or similar assets or liabilities in markets that are not active near the measurement date.
Level 3:Inputs include management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The inputs are unobservable in the market and significant to the instrument’s valuation.

 

The fair value of the Company’s cash equivalents and marketable securities was determined based on Level 1 and Level 2 inputs. The Company did not have any marketable securities in the Level 3 category as of June 30, 2020March 31, 2021 or September 30, 2019.2020. The Company believes that the recorded values of its other financial instruments approximate their current fair values because of their nature and respective relatively short maturity dates or durations and that interest rates approximate market rates.durations.

 

9

Instruments Measured at Fair Value on a Recurring Basis

 

Cash equivalents and marketable securities: The following tables present the Company’s cash equivalents and marketable securities’ costs, gross unrealized gains and losses, and fair value by major security type recorded as cash equivalents or short-term or long-term marketable securities as of June 30, 2020March 31, 2021 and September 30, 2019.2020. Unrealized gains and losses from the remeasurement of marketable securities are recorded in accumulated other comprehensive income (loss) until recognized in earnings upon the sale or maturity of the security.

 

 

June 30, 2020

  

March 31, 2021

 
 

Cost Basis

  

Unrealized

Gain

  

Fair Value

  

Cash

Equivalents

  

Short-term

Securities

  

Long-term

Securities

  

Cost Basis

  

Unrealized Gain

  

Fair Value

  

Cash Equivalents

  

Short-term Securities

  

Long-term Securities

 

Level 1:

                                                

Money Market Funds

 $1,037,567  $-  $1,037,567  $1,037,567  $-  $-  $538  $-  $538  $538  $-  $- 
                                                

Level 2:

                                                

Certificates of deposit

  1,943,206   -   1,943,206   -   499,000   1,444,206   1,193   -   1,193   -   251   942 

Municipal securities

  2,109,268   4,048   2,113,316   -   1,603,982   509,334   5,223   1   5,224   -   4,161   1,063 

Corporate bonds

  3,330,008   4,250   3,334,258   -   1,951,144   1,383,114   1,507   -   1,507   -   1,062   445 

Subtotal

  7,382,482   8,298   7,390,780   -   4,054,126   3,336,654   7,923   1   7,924   -   5,474   2,450 
                                                

Total

 $8,420,049  $8,298  $8,428,347  $1,037,567  $4,054,126  $3,336,654  $8,461  $1  $8,462  $538  $5,474  $2,450 

  

September 30, 2020

 
  

Cost Basis

  

Unrealized Gain

  

Fair Value

  

Cash Equivalents

  

Short-term Securities

  

Long-term Securities

 

Level 1:

                        

Money Market Funds

 $365  $-  $365  $365  $-  $- 
                         

Level 2:

                        

Certificates of deposit

  1,195   -   1,195   -   -   1,195 

Municipal securities

  3,777   4   3,781   -   2,432   1,350 

Corporate bonds

  3,091   3   3,094   -   1,833   1,260 

Subtotal

  8,063   7   8,070   -   4,265   3,805 
                         

Total

 $8,428  $7  $8,435  $365  $4,265  $3,805 

 

Foreign currency forward contract: In August 2020, the Company entered into a foreign currency forward contract as an economic hedge against exposure to changes in the Canadian dollar in connection with the Amika Mobile asset purchase. At September 30, 2020, the notional value of the foreign currency forward contract was CAD$6,955 with a maturity date in October 2020. The foreign currency forward contract was classified under Level 2 of the fair value hierarchy. The valuation techniques used to measure the fair value were based on quoted market prices. On October 1, 2020, the foreign currency forward contract was settled for CAD$6,955 (USD$5,281), resulting in a realized loss of $48 on the contract that was recorded in earnings as other income (expense). The foreign currency forward contract liability was recorded in accrued liabilities in the consolidated balance sheet as of September 30, 2020.

 

  

September 30, 2019

 
  

Cost Basis

  

Unrealized

Gain

  

Fair Value

  

Cash

Equivalents

  

Short-term

Securities

  

Long-term

Securities

 

Level 1:

                        

Money Market Funds

 $275,538  $-  $275,538  $275,538  $-  $- 
                         

Level 2:

                        

Certificates of deposit

  971,592   -   971,592   -   499,000   472,592 

Municipal securities

  240,463   205   240,668   -   80,336   160,332 

Corporate bonds

  3,856,766   11,157   3,867,923   -   3,116,028   751,895 

Subtotal

  5,068,821   11,362   5,080,183   -   3,695,364   1,384,819 
                         

Total

 $5,344,359  $11,362  $5,355,721  $275,538  $3,695,364  $1,384,819 
11

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

 

6. 7. INVENTORIES, NET

 

Inventories, net consisted of the following:

 

  

June 30,

  

September 30,

 
  

2020

  

2019

 

Raw materials

 $6,454,321  $5,060,331 

Finished goods

  1,115,923   998,607 

Work in process

  462,767   306,809 

Inventories, gross

  8,033,011   6,365,747 

Reserve for obsolescence

  (698,846)  (530,584)

Inventories, net

 $7,334,165  $5,835,163 

10

  

March 31,

  

September 30,

 
  

2021

  

2020

 

Raw materials

 $5,385  $5,220 

Finished goods

  718   841 

Work in process

  980   456 

Inventories, gross

  7,083   6,517 

Reserve for obsolescence

  (632)  (568)

Inventories, net

 $6,451  $5,949 

 

 

7. 8. PROPERTY AND EQUIPMENT, NET

 

Property and equipment, net consisted of the following:

 

 

June 30,

  

September 30,

  

March 31,

  

September 30,

 
 

2020

  

2019

  

2021

  

2020

 

Office furniture and equipment

 $1,568,585  $1,498,395  $1,233  $1,181 

Machinery and equipment

  1,237,617   1,223,726   1,230   1,184 

Leasehold improvements

  2,027,335   2,019,794   2,150   2,056 

Construction in progress

  7,565   7,565   16   8 

Property and equipment, gross

  4,841,102   4,749,480   4,629   4,429 

Accumulated depreciation

  (2,856,435)  (2,479,974)  (2,728)  (2,499)

Property and equipment, net

 $1,984,667  $2,269,506  $1,901  $1,930 

 

Depreciation expense was $130,981$101 and $150,327$132 for the three months ended June 30,March 31, 2021 and 2020, and 2019, respectively. Depreciation expense was $397,018$200 and $394,524$266 for the ninesix months ended June 30,March 31, 2021 and 2020, and 2019, respectively.

 

 

8. 9. GOODWILL AND INTANGIBLE ASSETS

 

Goodwill is attributable to the acquisition of Genasys Spain and the Amika Mobile asset purchase and is due to combining the integrated emergency critical communications, mass messaging solutions and software development capabilities with existing LRADhardware products for enhanced offerings and the skill level of the workforce.acquired workforces. The Company periodically reviews goodwill for impairment in accordance with relevant accounting standards. During the six months ended March 31, 2021, the Company added $5,590 in goodwill related to the Amika Mobile asset purchase. There were no additions or impairments to goodwill during the threesix months ended June 30, 2020.March 31, 2021.

 

Intangible assets and goodwill related to Genasys Spain are translated from Euros to U.S. dollars at the balance sheet date. The net impact of foreign currency exchange differences arising during the nine month period related to goodwill and intangible assets was an increase of $96,015.$4. Intangible assets and goodwill related to Amika Mobile are translated from Canadian dollars to U.S. dollars at the balance sheet date. During the six months ended March 31, 2021, the Company added $2,820 in intangible assets related to the Amika Mobile asset purchase. The net impact of foreign currency exchange differences arising during the period related to goodwill and intangible assets was an increase of $474. The Company’s intangible assets consisted of the following:

 

 

June 30,

  

September 30,

  

March 31,

  

September 30,

 
 

2020

  

2019

  

2021

  

2020

 

Technology

 $628,386  $611,043  $3,297  $655 

Customer relationships

  601,065   584,477   965   627 

Trade name portfolio

  218,569   212,537   228   228 

Non-compete agreements

  236,782   230,248   247   247 

Patents

  72,126   72,126   72   72 
  1,756,928   1,710,431   4,809   1,829 

Accumulated amortization

  (775,742)  (534,797)  (1,239)  (886)
 $981,186  $1,175,634  $3,570  $943 

12

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

Amortization expense was $74,049$169 and $75,354$74 for the three months ended June 30,March 31, 2021 and 2020, and 2019, respectively. Amortization expense was $223,042$352 and $228,793$149 for the ninesix months ended June 30,March 31, 2021 and 2020, and 2019, respectively.

 

As of June 30, 2020,March 31, 2021, future amortization expense is as follows:

 

Fiscal year ending September 30,

    

2020 (remaining three months)

 $75,592 

2021

  246,275 

Fiscal year ending September 30, 2021 (remaining six months)

 $330 

2022

  223,126   658 

2023

  191,882   625 

2024

  178,581   612 

2025

  482 

Thereafter

  65,730   863 

Total estimated amortization expense

 $981,186  $3,570 

 

11

 

 

9. 10. PREPAID EXPENSES AND OTHER

 

Prepaid expenses and other current assets consisted of the following:

 

 

June 30,

  

September 30,

  

March 31,

  

September 30,

 
 

2020

  

2019

  

2021

  

2020

 

Deposits for inventory

 $173,607  $1,064,640  $52  $54 

Prepaid insurance

  350,173   194,285   531   264 

Prepaid rent

  -   87,782 

Dues and subscriptions

  198,951   88,031   146   151 

Trade shows and travel

  116,024   106,626   92   103 

Other

  199,678   240,473   261   288 
 $1,052,750  $1,781,837  $1,082  $860 

 

Deposits for inventory

 

Deposits for inventory consisted of cash payments to vendors for inventory to be delivered in the future.

 

Prepaid Insuranceinsurance

 

Prepaid insurance consisted of premiums paid for health, commercial and corporate insurance. These premiums are amortized on a straight-line basis over the term of the agreements.

Prepaid Rent

Prepaid rent consists of payments made in advance for the Company’s facility lease.

 

Dues and subscriptions

 

Dues and subscriptions consist of payments made in advance for software subscriptions and trade and professional organizations. These payments are amortized on a straight-line basis over the term of the agreements.

 

Trade shows and travel

 

Trade shows and travel consists of payments made in advance for trade show events.

13

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

 

10. 11. ACCRUED LIABILITIES AND OTHER LIABILITIES - NONCURRENT

 

Accrued liabilities consisted of the following:

 

 

June 30,

  

September 30,

  

March 31,

  

September 30,

 
 

2020

  

2019

  

2021

  

2020

 

Payroll and related

 $1,872,141  $2,050,324  $2,054  $2,545 

Deferred revenue

  531,670   508,522   620   731 

Customer deposits

  5,766,808   5,063,091   3,169   3,683 

Accrued contract costs

  580,173   252,833   1,007   719 

Warranty reserve

  132,322   150,229   144   126 

Deferred rent

  -   109,342 

Other

  -   76 

Total

 $8,883,114  $8,134,341  $6,994  $7,880 

 

Other liabilities-noncurrent consisted of the following: 

 

 

June 30,

  

September 30,

  

March 31,

  

September 30,

 
 

2020

  

2019

  

2021

  

2020

 

Deferred rent

 $-  $1,881,387 

Deferred extended warranty revenue

  383,413   550,885  $214  $293 

Asset purchase holdback liability

  670   - 

Total

 $383,413  $2,432,272  $884  $293 

 

Payroll and related

 

Payroll and related consisted primarily of accrued vacation, bonus, sales commissions and benefits.

 

12

Deferred Revenue

 

Deferred revenue as of June 30, 2020March 31, 2021 included prepayments from customers for services, including extended warranty, scheduled to be performed in the twelve months ended June 30, 2021.ending March 31, 2022.

Customer Deposits

Customer deposits represent amounts paid by customers as a down payment on hardware orders to be delivered during the next twelve months.

 

Accrued contract costs

 

Accrued contract costs consist of accrued expenses for contracting a third-party service provider to fulfill repair and maintenance obligations required under a contract with a foreign military for units sold in the year ended September 30, 2011. Payments to the service provider will be made annually upon completion of each year of service. A new contract was signed with the customer in May 2019 to continue repair and maintenance services through May 2024. These services are being recorded in cost of revenues to correspond with the revenues for these services.

 

WarrantyWarranty Reserve

 

Changes in the warranty reserve and extended warranty were as follows:

 

 

June 30,

  

September 30,

  

March 31,

  

September 30,

 
 

2020

  

2019

  

2021

  

2020

 

Beginning balance

 $150,229  $99,216  $126  $150 

Warranty provision

  2,396   85,078   37   16 

Warranty settlements

  (20,303)  (34,065)  (19)  (40)

Ending balance

 $132,322  $150,229  $144  $126 

 

The Company establishes a warranty reserve based on anticipated warranty claims at the time product revenue is recognized. Factors affecting warranty reserve levels include the number of units sold, anticipated cost of warranty repairs and anticipated rates of warranty claims. The Company evaluates the adequacy of the provision for warranty costs each reporting period and adjusts the accrued warranty liability to an amount equal to estimated warranty expense for products currently under warranty.

 

Deferred Rent

Deferred rent liability as of September 30, 2019 consists of the difference between the average rental amount charged to expense and amounts payable under the lease for the Company’s operating facility. Deferred rent also includes cash and leasehold incentives from the landlord in the aggregate amount of $1,990,729 as of September 30, 2019 to compensate for costs incurred by the Company to make the office space ready for operation (leasehold incentives). Prior

14

Genasys Inc.
Notes to the adoption of Topic 842, leasehold incentives received from a landlord are deferredCondensed Consolidated Financial Statements

(in thousands, except per share and recognized on a straight-line basis as a reduction to rent expense over the lease term. Upon adoption of Topic 842, the leasehold incentives were a reduction to the measurement of the operating lease ROU asset. Refer to Note 3, Recent Accounting Pronouncements and Note 12, Leases for further detail on the adoption of Topic 842.share amounts)

(Unaudited)

 

Deferred Extended Warranty Revenue

 

Deferred extended warranty revenue consists of warranties purchased in excess of the Company’s standard warranty. Extended warranties typically range from one to two years.

Asset purchase holdback liability

In connection with the Amika Mobile asset purchase, the Company recorded a holdback liability related to future adjustments to assets and liabilities. Adjustments of up to CAD$1,000 (USD$794) will be deducted from the asset purchase holdback liability for up to three years from the closing date. The liability is recorded at fair value in the condensed consolidated balance sheet.

 

 

11.12. DEBT

 

In connection with the acquisition of Genasys Spain the Company acquiredassumed certain debts of Genasys Spain. The carrying value of the acquired debt approximates fair value. The balances of the acquired debt consist of loans with governmental agencies as of June 30, 2020.March 31, 2021. Loans with governmental agencies represent interest free debt granted by ministries within Spain for the purpose of stimulating economic development and promoting research and development. Loans with governmental agencies as of June 30, 2020March 31, 2021 are as follows:

 

Agency

Due Date

 

Principal

  

Due Date

 

Principal

  

Ministry of Economy and Competitiveness

February 2, 2022

  33,838  

February 2, 2022

 $18  

Ministry of Economy and Competitiveness

February 2, 2024

  270,604 

(a)

February 2, 2024

  282 

(a)

  $304,442    $300  

 

 

(a)

This loan is secured by $270,604$282 of cash pledged as collateral by Genasys Spain, which is the current balance of the loan. This amount is included in restricted cash at June 30, 2020.March 31, 2021. The Company expects the Ministry of Economy and Competitiveness to declare the terms of the loan satisfied within the next twelve months and that the outstanding balance of the loan will be paid in full during the next twelve months. Accordingly, this has been included in the current portion of notes payable as of June 30, 2020.March 31, 2021.

13

 

The following is a schedule of future annual payments as of June 30, 2020:March 31, 2021:

 

2021

 $287,523 

2022

  16,919  $300 

2023

  - 

Total

 $304,442  $300 

 

Revolving line of credit

On March 8, 2021, the Company entered into an agreement with MUFG Union Bank, N.A. for a $10 million revolving line of credit. Outstanding balances on the revolving line of credit bear interest at a per annum rate equal to the London Interbank Offered Rate (“LIBOR”) plus 2.25%. The current portionagreement contains a provision for determining an alternative interest rate index in the event the LIBOR rate is no longer available. The agreement contains standard covenants, including affirmative financial covenants, such as the maintenance of debta short-term liquidity ratio and a senior leverage ratio, in addition to negative covenants which limit the incurrence of additional indebtedness, loans and equity investments, disposition of assets, mergers and consolidations and other matters customarily restricted in such agreements. The maturity date of this revolving line of credit is $287,523March 31, 2023. As of March 31, 2021, there were no borrowings on the revolving line of credit. The Company incurred and capitalized $38 of issuance costs related to this revolving line of credit. These issuance costs have and will be amortized on a straight-line basis over the noncurrent portionterm of debt is $16,919.the loan.

 

 

12. 13. LEASES

 

The Company determines if an arrangement is a lease at inception. The guidance in Topic 842 defines a lease as a contract, or part of a contract, that conveys the right to control the use of identified property, plant, or equipment (an identified asset) for a period of time in exchange for consideration. Operating lease ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date. The Company’s leases do not provide an implicit rate. The Company uses its incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. Additionally, the portfolio approach is used in determining the discount rate used to present value lease payments. The operating ROU asset includes any lease payments made and excludes lease incentives and initial direct costs incurred.

15

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

The Company entered into operating leases for office and production facilities and equipment under agreements that expire at various dates through 2028. The Company elected the package of practical expedients permitted under the new lease standard. In electing the practical expedient package, the Company is not required to reassess whether an existing or expired contract is or contains a lease, reassess the lease classification for expired or existing leases nor reassess the initial direct costs for leases that commenced before the adoption of Topic 842. The Company also elected the short-term lease exemption such that the new lease standard was applied to leases greater than one year in duration. Leases with an initial term of twelve months or less are not recorded on the balance sheet. The Company recognizes lease expense for these leases on a straight-line basis over the lease term.

 

For leases beginning on or after October 1, 2019, lease components are accounted for separately from non-lease components for all asset classes. Certain of the Company’s leases contain renewal provisions and escalating rental clauses and generally require the Company to pay utilities, insurance, taxes and other operating expenses. The renewal provisions of existing lease agreements were not included in the determination of the operating lease liabilities and the operating ROU assets. Variable payments such as excess usage fees on existing equipment leases were not included in the determination of the lease liabilities and the operating ROU assets as the achievement of the specified target that triggers the variable lease payment is not considered probable. In addition, the Company’s facility lease in Spain has an escalating lease clause based on a consumer price index which is considered a variable lease payment and is not included in the determination of the lease liability and operating ROU asset. A 10% increase in the index would increase the total lease liability approximately $19,000.$19. The Company’s leases do not contain any residual value guarantees or material restrictive covenants.

 

Upon adoption of Topic 842 as of October 1, 2019, the Company recognized on its consolidated balance sheet an initial measurement of approximately $7,814,701$7,815 of operating lease liabilities, and approximately $5,823,972$5,824 of corresponding operating ROU assets, net of tenant improvement allowances. There was no cumulative effect adjustment to retained earnings as a result of the transition to Topic 842. The adoption of Topic 842 did not have a material impact on the Company’s consolidated statement of operations.

 

During the six months ended March 31, 2021, the Company added an additional operating ROU asset of $259 and operating lease liabilities of $259 for office space. The tables below show the initial measurement of the operating lease ROU assets and liabilities as of October 1, 2019September 30, 2020 and the balances as of June 30, 2020,March 31, 2021, including the changes during the periods.

 

  

Operating right-of-use asset

 

Initial measurement at October 1, 2019

 $7,814,701 

Less lease incentives and tenant improvement allowance

  (1,990,729)

Net operating lease right of use assets at October 1, 2019

  5,823,972 

Additional operating lease right of use assets

  42,660 

Less amortization of operating lease right-of-use assets

  (445,692)

Effect of exchange rate on operating lease right of use assets

  7,228 

Operating lease right of use asset at June 30, 2020

 $5,428,168 
  

Operating ROU assets

 

Operating lease right of use asset at September 30, 2020

 $5,285 

Additional operating lease right of use assets

  259 

Less amortization of operating lease right-of-use assets

  (343)

Effect of exchange rate on operating lease right of use assets

  15 

Operating lease right of use asset at March 31, 2021

 $5,216 

  

Operating lease liabilities

 

Operating lease liabilities at September 30, 2020

 $7,166 

Additional operating lease liabilities

  259 

Less lease principal payments on operating lease liabilities

  (409)

Effect of exchange rate on operating lease liabilities

  15 

Operating lease liabilities at March 31, 2021

  7,031 

Less non-current portion

  (6,172)

Current portion at March 31, 2021

 $859 

 

1416

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

  

Operating lease liabilities

 

Initial measurement at October 1, 2019

 $7,814,701 

Additional operating lease liabilities

  42,660 

Less lease principal payments on operating lease liabilities

  (526,022)

Effect of exchange rate on operating lease liabilities

  7,228 

Operating lease liabilities at June 30, 2020

  7,338,567 

Less non-current portion

  (6,586,196)

Current portion at June 30, 2020

 $752,371 

(Unaudited)

 

As of June 30, 2020,March 31, 2021, the Company’s operating leases have a weighted-average remaining lease term of 7.97.11 years and a weighted-average discount rate of 4.13%. The maturities of the operating lease liabilities are as follows:

 

Fiscal year ending September 30, 2020 (remaining three months)

 $255,632 

2021

  1,042,699 

Fiscal year ending September 30, 2021 (remaining six months)

 $569 

2022

  1,069,677   1,141 

2023

  1,021,173   1,090 

2024

  1,017,196   1,085 

2025

  1,162 

Thereafter

  4,248,721   3,104 

Total undiscounted operating lease payments

  8,655,098   8,151 

Less imputed interest

  (1,316,531)  (1,120)

Present value of operating lease liabilities

  7,338,567  $7,031 

Less lease liability, noncurrent

  (6,586,196)

Lease liability, current portion

 $752,371 

 

For the three months ended June 30,March 31, 2021 and 2020, and 2019, total lease expense under operating leases was approximately $226,083$245 and $224,407$224, respectively. For the ninesix months ended June 30,March 31, 2021 and 2020, and 2019, total lease expense under operating leases was approximately $674,108$490 and $663,500,$448, respectively. The Company did not have anyFor the three and six months ended March 31, 2021 total short-term lease expense was $2. There was no short-term lease expense during the three and ninesix months ended June 30,March 31, 2020.

 

 

13. 14. INCOME TAXES

 

For the ninesix months ended June 30,March 31, 2021, the Company recorded income tax expense of $278 reflecting an effective tax rate of 22.1%. For the six months ended March 31, 2020, the Company recorded income tax expense of $742,490$269 reflecting an effective tax rate of 22.8%. For the nine months ended June 30, 2019, the Company recorded an income tax expense of $675,457 reflecting an effective tax rate of 20.0%21.6%. The Company continues to maintain a partial valuation allowance against its deferred tax assets as the Company believes that the negative evidence that it will be able to recover these net deferred tax assets outweighs the positive evidence.

 

Accounting Standards Codification Topic 740, Accounting for Uncertainty in Income Taxes, requires the Company to recognize in its consolidated financial statements uncertainties in tax positions taken that may not be sustained upon examination by the taxing authorities. If interest or penalties are assessed, the Company would recognize these charges as income tax expense. The Company has not recorded any income tax expense or benefit for uncertain tax positions.

 

 

14.15. COMMITMENTS AND CONTINGENCIES

 

Litigation

 

The Company may at times be involved in litigation in the ordinary course of business. The Company will, from time to time, when appropriate in management’s estimation, record adequate reserves in the Company’s consolidated financial statements for pending litigation. Currently, there are no pending material legal proceedings to which the Company is a party or to which any of its property is subject.

 

Bonus Plan

 

The Company has a bonus plan for employees, in accordance with their terms of employment, whereby they can earn a percentage of their salary based on meeting targeted objectives for orders received, revenue, operating income and operating cash flow. In the ninesix months ended June 30, 2020,March 31, 2021, the Company recorded $1,143,267$898 of bonus expense. In the ninesix months ended June 30, 2019,March 31, 2020, the Company recorded $902,274$400 of bonus expense. Bonus expense

Amika Mobile Asset Purchase

In connection with the Amika Mobile asset purchase, the Company recorded a holdback liability related to future adjustments to assets and liabilities. Adjustments of up to CAD$1,000 (USD$794) will be deducted from the asset purchase holdback liability for up to three years from the closing date. The liability is recorded at fair value in accrued liabilities on the Company’s condensed consolidated balance sheet assheet.

The Company also agreed to issue 191,267 shares of June 30, 2020the Company’s common stock to the former owners of Amika Mobile on each of the first, second and September 30, 2019.third anniversaries of the closing date. The total number of shares of common stock the Company is obligated to issue is 573,801. The fair value of the Company’s common stock on the closing date was $5.98, resulting in the addition of $3,431 to additional paid-in-capital.

 

1517

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

15.16. SHARE-BASED COMPENSATION

 

Stock Option Plans

 

At June 30, 2020,March 31, 2021, the Company had two equity incentive plans. The 2005 Equity Incentive Plan (“2005 Equity Plan”) was terminated with respect to new grants in March 2015 but remains in effect for grants issued prior to that time. The Amended and Restated 2015 Equity Incentive Plan (“2015 Equity Plan”) was approvedadopted by the Company’s Board of Directors on December 6, 2016 and approved by the Company’s stockholders on March 14, 2017 and2017. The 2015 Equity Plan was amended by the Company’s Board of Directors on December 8, 2020 to increase the number of shares authorized for issuance from 5,000,000 to 10,000,000. On March 16, 2021, the Company’s stockholders approved a plan amendment. The 2015 Equity Plan authorizes forthe issuance of stock options, restricted stock, stock appreciation rights, restricted stock units and performance awards, to an aggregate of 5,000,00010,000,000 new shares of common stock to employees, directors, advisors or consultants. At June 30, 2020,March 31, 2021, there were options and restricted stock units outstanding covering 191,00092,500 and 2,842,4442,956,887 shares of common stock under the 2005 Equity Plan and 2015 Equity Plan, respectively and 604,2305,206,915 shares of common stock available for grant for a total of 3,637,6748,256,302 shares of common stock currently availableauthorized and unissued under the two equity plans.

 

Share-Based Compensation

 

The Company’s employee stock options have various restrictions that reduce option value, including vesting provisions and restrictions on transfer and hedging, among others, and are often exercised prior to their contractual maturity.

 

There were 245,000 stock options granted during the six months ended March 31, 2021. There were 1,133,727 stock options granted during the nine months ended June 30,fiscal 2020. There were no stock options granted during the nine months ended June 30, 2019. The weighted average estimated fair value of employee stock options granted during the ninesix months ended June 30, 2020March 31, 2021 was calculated using the Black-Scholes option-pricing model with the following weighted average assumptions (annualized percentages):

 

Volatility

44.5%

Risk Free Interest Rate

1.40%

Forfeiture rate

10.0%

Dividend Yield

0.0%

Expected life in years

5.35
  

Six months ended

 
  

March 31,

 
  

2021

  

2020

 

Volatility

  48.5%   44.5% 

Risk-free interest rate

  0.6%   1.4% 

Dividend yield

  0.0%   0.0% 

Expected term

  6.8   5.4 

 

Expected volatility is based on the historical volatility of the Company’s common stock over the period commensurate with the expected lifeterm of the options. The risk-free interest rate is based on rates published by the Federal Reserve Board. The contractual term of the options was seven years. The expected lifeterm is based on observed and expected time to post-vesting exercise. The expected forfeiture rate is based on past experience and employee retention data. Forfeitures are estimated at the time of the grant and revised in subsequent periods if actual forfeitures differ from those estimates. Such revision adjustments to expense will be recorded as a cumulative adjustment in the period in which the estimate is changed. The Company has not paid a dividend in fiscal 2021 and did not pay a dividend in fiscal 2019.2020.

 

As of June 30, 2020,March 31, 2021, there was approximately $378,436$812 of total unrecognized compensation costs related to outstanding employee stock options. This amount is expected to be recognized over a weighted average period of 2.022.4 years. To the extent the forfeiture rate is different from what the Company anticipated, stock-based compensation related to these awards will be different from the Company’s expectations.

 

Performance-Based Stock Options

 

On August 1, 2016, the Company awarded a performance-based stock option (PVO) to purchase 750,000 shares of the Company’s common stock to a key executive, with a contractual term of seven years. At the grant date, there were 375,000 performance-based stock options assigned to performance criteria within each of fiscal 2019 and 2020. Vesting is based upon the achievement of certain performance criteria for each of fiscal 2019 and 2020 including a minimum free cash flow margin and net revenue targets. Additionally, vesting is subject to the executive being employed by the Company at the time the Company achieves such financial targets.  As of September 30,

The Company determined that certain performance conditions related to the 2019 and 2020 performance criteria were achieved. 187,500 of the options related to the 2019 performance criteria vested and 375,000 options related to the 2020 performance criteria vested. The Company recorded $151,181a total of $459 in stock basedstock-based compensation expense for these options. This agreement was modifiedoptions through September 30, 2020, in October 2019,selling, general and 93,750administrative expenses in the consolidated statement of the unvested options initially allocatedoperations.

18

Genasys Inc.
Notes to the performance criteria for 2019 were assigned to fiscal 2020.Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

On October 4, 2019, the Company awarded a performance-based stock option (PVO) to purchase 800,000 shares of the Company’s common stock to a key executive, with a contractual term of seven years. Vesting is based upon the achievement of certain performance criteria for each of fiscal 2022 and 2023 including a minimum free cash flow margin and net revenue targets. Additionally, vesting is subject to the executive being employed by the Company at the time the Company achieves such financial targets. The Company has not recorded stock-based compensation expense related to these options.

 

The Company determined that as of June 30, 2020, it is probable that certain performance conditions related todid not grant any PVO’s during the 2020 performance criteria will be achieved. During the three and ninesix months ended June 30, 2020, the Company recorded $153,873 and $249,623 in stock based compensation expense related to performance-based stock options. The Company will continue to review these targets each quarter and will adjust the expected outcome as needed, recognizing compensation expense cumulatively in such period for the difference in expense.March 31, 2021.

16

 

Restricted Stock Units

 

During fiscal 2018, the Board of Directors granted 93,330 restricted stock units (“RSUs”) to employees that will vest equally over three years on each of the first three anniversary dates of the grant. These were issued at a market value of $210,176,$210, which will be expensed on a straight linestraight-line basis over the three-year life of the grants.

 

On February 7,During fiscal 2019, the Board of Directors approved non-employee director compensation to include an annual grant of 30,000 RSUs to each of the Company’s five non-employee directors that will vest on the first anniversary of the grant date. These were issued at a market value of $412,500, which have been and were expensed on a straight-line basis through the March 12, 2020 vest date. Also, during fiscal 2019,granted 99,300 RSUs were granted to employees that will vest equally over three years on each of the first three anniversary dates of the grant. These were issued at a market value of $248,250,$248, which have and will be expensed on a straight linestraight-line basis over the three yearthree-year life of the grants.

 

On March 10, 2020, each non-employee member of the Board of Directors received a grant of 30,000 RSUs that will vestvested on the first anniversary of the grant date. These were issued at a market value of $424,500,$425, which have and will bewere expensed on a straight-line basis through the March 10, 2021 vest date. Also, in fiscal 2020, 81,270 RSUs were granted to employees during the first nine months of 2020 that will vest over three years on the anniversary date of the grant. These were issued at a market value of $257,626,$258, which have and will be expensed on a straight-line basis over the three-year life of the grants.

On March 16, 2021, each member of the Board of Directors received a grant of 27,883 RSUs that vested on the first anniversary of the grant date. These were issued at a market value of $1,100, which have and will be expensed on a straight-line basis through the March 16, 2022 vest date. Also, during the quarter, 107,200 RSUs were granted to employees that will vest over three years on the anniversary date of the grant. These were issued at a market value of $793, which have and will be expensed on a straight-line basis over the three-year life of the grants.

 

During the ninesix months ended June 30,March 31, 2021, the Company retained 22,073 shares of common stock to satisfy tax withholding obligations upon the vesting of RSUs issued to employees. During the six months ended March 31, 2020, the Company retained 13,063 shares of common stock to satisfy tax withholding obligations upon the vesting of RSUs issued to employees. These shares were not acquired pursuant to any repurchase plan or program. During the nine months ended June 30, 2019, there were no shares retained to satisfy withholding obligations in connection with the vesting of RSUs issued to employees.

 

Compensation expense for RSUs was $136,415$249 and $387 for the three months and six months ended June 30, 2020.March 31, 2021, respectively.. Compensation expense for RSUs was $430,506 for the nine months ended June 30, 2020. Compensation expense for RSUs was $124,991$168 and $294 for the three and six months ended June 30, 2019 and $344,473 for the nine months ended June 30, 2019.March 31, 2020, respectively. As of June 30, 2020,March 31, 2021, there was approximately $675,622$1,713 of total unrecognized compensation costs related to outstanding RSUs. This amount is expected to be recognized over a weighted average period of 1.311.71 years.

 

A summary of the restricted stock units of the Company as of June 30, 2020March 31, 2021 is presented below:

 

 

Number of

Shares

  

Weighted

Average Grant

Date Fair Value

  

Number of Shares

  

Weighted

Average Grant

Date Fair Value

 

Outstanding September 30, 2019

  274,849  $2.59 

Outstanding September 30, 2020

  303,014  $2.82 

Granted

  231,270  $2.95   246,565  $7.68 

Released

  (198,106) $2.66   (223,633) $2.78 

Forfeited/cancelled

  (4,999) $2.58   (277) $2.26 

Outstanding June 30, 2020

  303,014  $2.82 

Outstanding March 31, 2021

  325,669  $6.53 

19

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

Stock Option Summary Information

 

A summary of the activity in options to purchase the capital stock of the Company as of June 30, 2020March 31, 2021 is presented below:

 

 

Number of

Shares

  

Weighted

Average

Exercise Price

  

Number of

Shares

  

Weighted

Average

Exercise Price

 

Outstanding September 30, 2019

  2,219,268  $1.94 

Outstanding September 30, 2020

  2,659,305  $2.56 

Granted

  1,133,727  $3.39   245,000  $7.01 

Forfeited/expired

  (110,546) $2.11   (94,125) $1.99 

Exercised

  (512,019) $1.95   (86,462) $1.97 

Outstanding June 30, 2020

  2,730,430  $2.54 

Exerciseable June 30, 2020

  1,153,024  $2.00 

Outstanding March 31, 2021

  2,723,718  $3.00 

Exerciseable March 31, 2021

  1,480,606  $2.14 

 

Options outstanding are exercisable at prices ranging from $1.31 to $3.40$8.03 per share and expire over the period from 20202021 to 20262028 with an average life of 4.54.27 years. The aggregate intrinsic value of options outstanding and exercisable at June 30, 2020March 31, 2021 was $6,327,111$10,137 and $3,292,311,$6,742, respectively. The aggregate intrinsic value represents the difference between the Company’s closing stock price on the last day of trading for the quarter, which was $4.86$6.69 per share, and the exercise price multiplied by the number of applicable options. The total intrinsic value of stock options exercised during the ninesix months ended June 30, 2020March 31, 2021 was $2,232,469$455 and proceeds from these exercises were $996,891.$170. The total intrinsic value of stock options exercised during the ninesix months ended June 30, 2019March 31, 2020 was $97,609$242 and proceeds from these exercises were $54,621.$258. 

17

 

The following table summarized information about stock options outstanding at June 30, 2020:March 31, 2021:

 

Range of

Exercise Prices

 

 

Number

Outstanding

  

Weighted Average

Remaining

Contractual Life

  

Weighted Average

Exercise

Price

  

 

Number

Exercisable

  

Weighted Average

Exercise

Price

 
       

Weighted Average

  

Weighted Average

      

Weighted Average

 

Range of

Range of

 

Number

  

Remaining

  

Exercise

  

Number

  

Exercise

 

Exercise Prices

Exercise Prices

 

Outstanding

  

Contractual Life

  

Price

  

Exercisable

  

Price

 

$1.31

-$1.86  406,953   2.96  $1.67   369,451  $1.66 -$1.86  334,991   2.50  $1.64   321,241  $1.64 

$1.99

-$1.99  1,031,250   3.64  $1.99   562,500  $1.99 -$1.99  937,500   2.94  $1.99   937,500  $1.99 

$2.02

-$3.17  158,500   1.28  $2.30   158,500  $2.30 

$2.16

-$3.17  72,500   0.85  $2.52   72,500  $2.52 

$3.39

-$3.40  1,133,727   6.34  $3.39   62,573  $3.40 -$3.40  1,133,727   5.59  $3.39   125,147  $3.40 

$6.87

-$8.03  245,000   6.71  $7.01   24,218  $6.87 
    2,730,430   4.52  $2.54   1,153,024  $2.00     2,723,718   4.27  $3.00   1,480,606  $2.14 

 

The Company recorded $185,610$79 and $124,991$128 of stock option compensation expense for employees, directors and consultants for the three months ended June 30,March 31, 2021, and 2020, and 2019, respectively. The Company recorded $345,136$123 and $218,915$160 of stock option compensation expense for employees, directors and consultants for the ninesix months ended June 30,March 31, 2021, and 2020, and 2019, respectively.

 

Share-Based Compensation

 

The Company recorded share-based compensation expense and classified it in the condensed consolidated statements of operations as follows:

 

 

Three months ended

  

Nine months ended

  

Three months ended

  

Six months ended

 
 

June 30

  

June 30

  

March 31,

  

March 31,

 
 

2020

  

2019

  

2020

  

2019

  

2021

  

2020

  

2021

  

2020

 

Cost of revenues

 $4,861  $3,627  $15,412  $12,126  $9  $7  $15  $11 

Selling, general and administrative

  310,997   242,660   738,238   508,763   309   283   479   427 

Research and development

  6,167   11,279   21,992   42,499   10   6   16   16 
 $322,025  $257,566  $775,642  $563,388  $328  $296  $510  $454 

 

1820

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

117. STOCKHOLDERS6. STOCKHOLDERS’ EQUITY

 

Summary

 

The following tables summarizetable summarizes changes in the components of stockholders’ equity during the three and ninesix months ended June 30, 2020March 31, 2021 and the three and ninesix months ended June 30, 2019:March 31, 2020 (amounts in thousands, except par value and share amounts):

 

                 

Accumulated

                      

Accumulated

     
         

Additional

      

Other

  

Total

          

Additional

      

Other

  

Total

 
 

Common Stock

  

Paid-in

  

Accumulated

  

Comprehensive

  

Stockholders'

  

Common Stock

  

Paid-in

  

Accumulated

  

Comprehensive

  

Stockholders'

 
 

Shares

  

Amount

  

Capital

  

Deficit

  

Loss

  

Equity

  

Shares

  

Amount

  

Capital

  

Deficit

  

Loss

  

Equity

 

Balance at September 30, 2019

  32,949,987  $330  $89,571,641  $(53,731,903) $(458,719) $35,381,349 

Balance at September 30, 2020

  33,561,544  $336  $91,248  $(41,858) $(250) $49,140 

Share-based compensation expense

  -   -   158,327   -   -   158,327   -   -   182   -   -   182 

Issuance of common stock upon exercise of stock options, net

  83,343   1   144,213   -   -   144,214   25,899   -   54   -   -   54 

Obligation to issue common stock

  -   -   3,431   -   -   3,431 

Other comprehensive income

  -   -   -   -   85,314   85,314   -   -   -   -   469   469 

Net income

  -   -   -   620,327   -   620,327 

Balance at December 31, 2019

  33,033,330  $331  $89,874,181  $(53,111,576) $(373,405) $36,389,531 

Net loss

  -   -   -   (619)  -   (619)

Balance at December 31, 2020

  33,587,443  $336  $94,915  $(42,477) $219  $52,657 
                                                

Share-based compensation expense

  -   -   295,290   -   -   295,290   -  $-  $328  $-  $-  $328 

Issuance of common stock upon exercise of stock options, net

  56,861   -   113,833   -   -   113,833   60,563   1   116   -   -   116 

Issuance of common stock upon vesting of restricted stock units

  198,106   2   (2)  -   -   -   223,633   2   -   -   -   - 

Shares retained for payment of taxes in connection with net share settlement of restricted stock units

  (13,063)  -   (41,410)  -   -   (41,410)  (22,073)  -   (141)  -   -   (141)

Stock buyback

  (156,505)  (2)  (398,254)          (398,256)

Other comprehensive loss

  -   -   -   -   (69,352)  (69,352)  -   -   -   -   (78)  (78)

Net income

  -   -   -   301,575   -   301,575   -   -   -   262   -   262 

Balance at March 31, 2020

  33,118,729  $331  $89,843,638  $(52,810,001) $(442,757) $36,591,211 
                        

Share-based compensation expense

  -   -   322,025   -   -   322,025 

Issuance of common stock upon exercise of stock options, net

  371,815   4   738,840   -   -   738,844 

Other comprehensive income

  -   -   -   -   51,274   51,274 

Net income

  -   -   -   1,504,077   -   1,504,077 

Balance at June 30, 2020

  33,490,544  $335  $90,904,503  $(51,305,924) $(391,483) $39,207,431 

Balance at March 31, 2021

  33,849,566  $339  $95,218  $(42,215) $141  $53,144 

 

                  

Accumulated

     
          

Additional

      

Other

  

Total

 
  

Common Stock

  

Paid-in

  

Accumulated

  

Comprehensive

  

Stockholders'

 
  

Shares

  

Amount

  

Capital

  

Deficit

  

Loss

  

Equity

 

Balance at September 30, 2018

  33,176,146  $332  $90,251,145  $(56,516,895) $(245,375) $33,489,207 

Share-based compensation expense

  -   -   133,845   -   -   133,845 

Issuance of common stock upon exercise of stock options, net

  1,600   -   2,528   -   -   2,528 

Stock buyback

  (588,425)  (6)  (1,621,016)  -   -   (1,621,022)

Other comprehensive loss

  -   -   -   -   (54,335)  (54,335)

Net income

  -   -   -   1,045,940   -   1,045,940 

Balance at December 31, 2018

  32,589,321  $326  $88,766,502  $(55,470,955) $(299,710) $32,996,163 
                         

Share-based compensation expense

  -   -   171,977   -   -   171,977 

Issuance of common stock upon exercise of stock options, net

  26,682   -   42,644   -   -   42,644 

Issuance of common stock upon vesting of restricted stock units

  156,115   2   (2)  -   -   - 

Stock buyback

  (200,000)  (2)  (549,998)  -       (550,000)

Other comprehensive loss

  -   -   -   -   (69,091)  (69,091)

Net income

  -   -   -   1,178,850   -   1,178,850 

Balance at March 31, 2019

  32,572,118  $326  $88,431,123  $(54,292,105) $(368,801) $33,770,543 
                         

Share-based compensation expense

  -   -   257,566   -   -   257,566 

Issuance of common stock upon exercise of stock options, net

  7,000   -   9,449   -   -   9,449 

Other comprehensive loss

  -   -   -   -   56,538   56,538 

Net income

  -   -   -   638,041   -   638,041 

Balance at June 30, 2019

  32,579,118  $326  $88,698,138  $(53,654,064) $(312,263) $34,732,137 

19

          

Additional

      

Other

  

Total

 
  

Common Stock

  

Paid-in

  

Accumulated

  

Comprehensive

  

Stockholders'

 
  

Shares

  

Amount

  

Capital

  

Deficit

  

Loss

  

Equity

 

Balance at September 30, 2019

  32,949,987  $330  $89,572  $(53,732) $(459) $35,381 

Share-based compensation expense

  -   -   158   -   -   158 

Issuance of common stock upon exercise of stock options, net

  83,343   1   144   -   -   144 

Other comprehensive loss

  -   -   -   -   85   85 

Net income

  -   -   -   620   -   620 

Balance at December 31, 2019

  33,033,330  $331  $89,874  $(53,112) $(374) $36,388 
                         

Share-based compensation expense

  -  $-  $296  $-  $-  $296 

Issuance of common stock upon exercise of stock options, net

  56,861   -   114   -   -   114 

Issuance of common stock upon vesting of restricted stock units

  198,106   2   -   -   -   - 

Shares retained for payment of taxes in connection with net share settlement of restricted stock units

  (13,063)  -   (41)  -   -   (41)

Stock buyback

  (156,505)  (2)  (398)  -   -   (398)

Other comprehensive loss

  -   -   -   -   (69)  (69)

Net loss

  -   -   -   302       302 

Balance at March 31, 2020

  33,118,729  $331  $89,845  $(52,810) $(443) $36,592 

 

Common Stock Activity

 

On March 18, 2021, the Company filed an amendment to its Certificate of Incorporation, as amended, with the Secretary of State of Delaware to increase the authorized number of shares of common stock of the Company from 50,000,000 to 100,000,000 shares (the “Amended Certificate”). The Amended Certificate was approved by the Company’s stockholders at the Company’s Annual Meeting of Stockholders on March 16, 2021.

21

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

During the ninesix months ended June 30, 2020,March 31, 2021, the Company issued 512,01986,462 shares of common stock and obtainedreceived gross proceeds of $996,891$170 in connection with the exercise of stock options. During the ninesix months ended June 30, 2019,March 31, 2020, the Company issued 35,282140,204 shares of common stock and obtainedreceived gross proceeds of $54,621$258 in connection with the exercise of stock options. During the ninesix months ended June 30,March 31, 2021, the Company issued 201,560 shares of commons stock in connection with the vesting of RSUs. During the six months ended March 31, 2020, the Company issued 185,043 shares of common stock in connection with the vesting of RSUs. During

In connection with the nine months ended June 30, 2019,Amika Mobile asset purchase, the Company issued 156,115agreed to issue 191,267 shares of the Company’s common stock to the former owners of Amika Mobile on each of the first, second and third anniversaries of the closing date. The total number of shares of common stock the Company is obligated to issue is 573,801. The fair value of the Company’s common stock on the closing date was $5.98, resulting in connection with the vestingaddition of RSUs.$3,431 to additional paid-in-capital.

 

Share Buyback Program

The Board of Directors approved a share buyback program in 2015 under which the Company was authorized to repurchase up to $4 million of its outstanding common shares. In December 2017, the Board of Directors extended the program through December 31, 2018.

 

In December 2018, the Board of Directors approved a new share buyback program beginning January 1, 2019 and expiring on December 31, 2020, under which the Company was authorized to repurchase up to $5 million of its outstanding common shares. In December 2020, the Board of Directors extended the buyback program until December 31, 2022. The previous program expired on December 31, 2018.

 

During the ninesix months ended June 30,March 31, 2021 no shares were repurchased by the Company. During the six months ended March 31, 2020, the Company repurchased 156,505 shares for $398,256. During the nine months ended June 30, 2019, 788,425 shares were repurchased for $2,171,022. All repurchased shares were retired.$398.

 

Dividends

 

There were no dividends declared in the ninesix months ended June 30, 2020March 31, 2021 and 2019.2020.

 

 

17.18. NET (LOSS) INCOME PER SHARE

 

The following table sets forth the computation of basic and diluted net income per share:

 

  

Three months Ended

  

Nine months Ended

 
  

June 30,

  

June 30,

 
  

2020

  

2019

  

2020

  

2019

 

Net income

 $1,504,077  $638,041  $2,425,979  $2,862,831 
                 

Basic income per share

 $0.05  $0.02  $0.07  $0.09 

Diluted income per share

 $0.04  $0.02  $0.07  $0.09 
                 

Weighted average shares outstanding - basic

  33,289,426   32,575,118   33,122,042   32,684,311 

Assumed exercise of dilutive options

  991,489   797,659   756,201   656,746 

Weighted average shares outstanding - diluted

  34,280,915   33,372,777   33,878,243   33,341,057 
                 

Potentially diluted securities outstanding at period end excluded from diluted computation as the inclusion would have been antidilutive:

                

Options

  893,750   761,250   893,750   976,750 

20

  

Three months ended

  

Six months ended

 
  

March 31,

  

March 31,

 
  

2021

  

2020

  

2021

  

2020

 

Net income (loss)

 $262  $302  $(357) $922 
                 

Basic income (loss) per share

 $0.01  $0.01  $(0.01) $0.03 

Diluted income (loss) per share

 $0.01  $0.01  $(0.01) $0.03 
                 

Weighted average shares outstanding - basic

  33,683,240   33,094,596   33,629,479   33,036,786 

Assumed exercise of dilutive options

  1,096,026   638,023   -   672,046 

Weighted average shares outstanding - diluted

  34,779,266   33,732,619   33,629,479   33,708,832 
                 

Potentially diluted securities outstanding at period end excluded from diluted computation as the inclusion would have been antidilutive:

                

Options

  830,000   1,602,477   2,723,718   1,602,477 

RSU

  -   -   325,669   - 

Total

  830,000   1,602,477   3,049,387   1,602,477 

 

 

18. 19. SEGMENT INFORMATION

 

The Company is engaged in the design, development and commercialization of directed and multidirectional sound technologies, voice broadcast products and location-based mass messaging solutions for emergency warning and workforce management. The Company operates in two business segments: Hardware and Software and its principleprincipal markets are North and South America, Europe, the Middle East and Asia. As reviewed by the Company’s chief operating decision maker, the Company evaluates the performance of each segment based on sales and operating income. Cash and cash equivalents, marketable securities, accounts receivable, inventory, property and equipment, deferred tax assets, goodwill and intangible assets are primary assets identified by segment. The accounting policies for segment reporting are the same for the Company as a wholewhole.

22

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and transactions between the two operating segments are not material.share amounts)

(Unaudited)

 

The following table presents the Company’s segment disclosures:

 

 

Three months ended March 31,

  

Six months ended March 31,

 
 

Three months ended June 30,

  

Nine months ended June 30,

  

2021

  

2020

  

2021

  

2020

 
 

2020

  

2019

  

2020

  

2019

                 

Revenue from external customers

                                

Hardware

 $11,604,345  $8,302,811  $27,832,550  $27,606,026  $10,625  $7,862  $18,012  $16,221 

Software

  366,751   560,915   1,197,021   1,626,950   676   414   1,317   837 
 $11,971,096  $8,863,726  $29,029,571  $29,232,976  $11,301  $8,276  $19,329  $17,058 
                                

Intercompany revenues

                

Intersegment revenues

                

Hardware

 $-  $-  $-  $-  $-  $-  $-  $- 

Software

  552,433   257,302   1,381,335   724,271   254   444   606   829 
 $552,433  $257,302  $1,381,335  $724,271  $254  $444  $606  $829 
                                

Segment operating income (loss)

                                

Hardware

 $1,971,174  $660,106  $3,047,418  $3,245,060  $1,566  $523  $1,724  $1,381 

Software

  (29,992)  26,355   (80,838)  166,662   (1,013)  (194)  (1,864)  (356)
 $1,941,182  $686,461  $2,966,580  $3,411,722  $553  $329  $(140) $1,025 
                                

Other expenses:

                                

Depreciation and amortization expense

                                

Hardware

 $127,166  $149,331  $386,641  $392,296  $93  $128  $183  $259 

Software

  77,864   76,350   233,419   231,021   177   78   369   156 
 $205,030  $225,681  $620,060  $623,317  $270  $206  $552  $415 
                                

Interest expense

                

Hardware

 $-  $-  $-  $- 

Software

  22   -   22   - 
 $22  $-  $22  $- 

Income tax expense

                                

Hardware

 $473,332  $118,310  $742,490  $675,457  $283  $97  $278  $269 

Software

  -   -   -   -   -   -   -   - 
 $473,332  $118,310  $742,490  $675,457  $283  $97  $278  $269 

 

 

June 30, 2020

  

September 30, 2019

  

March 31, 2021

  

September 30, 2020

 

Long-lived assets

                

Hardware

 $1,982,351  $2,283,344  $1,888  $1,924 

Software

  3,354,692   3,467,546   11,963   3,421 
 $5,337,043  $5,750,890  $13,851  $5,345 
                

Total assets

                

Hardware

 $54,070,323  $42,470,356  $55,933  $61,152 

Software

  4,953,721   4,649,627   14,975   5,015 
 $59,024,044  $47,119,983  $70,908  $66,167 

 

21

 

19.20. MAJOR CUSTOMERS,, SUPPLIERS AND RELATED INFORMATION

 

For the three months ended June 30,March 31, 2021, revenues from one customer accounted for 47% of total revenues with no other single customer accounting for more than 10% of revenues. For the six months ended March 31, 2021, revenues from one customer accounted for 49% of total revenues with no other single customer accounting for more than 10% of revenues. As of March 31, 2021, accounts receivable from two customers accounted for 33% and 25% of total accounts receivable, with no other single customer accounting for more than 10% of the accounts receivable balance.

23

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

For the three months ended March 31, 2020, revenues from one customer accounted for 64% of total revenues with no other single customer accounting for more than 10% of revenues. For the ninesix months ended June 30,March 31, 2020, revenues from one customer accounted for 63% of total revenues with no other single customer accounting for more than 10% of revenues. As of June 30,March 31, 2020, accounts receivable from two customers accounted for 60%63% and 17%15% of total accounts receivable, with no other single customer accounting for more than 10% of the accounts receivable balance.

 

ForRevenue from customers in the United States was $8,086 and $6,411 for the three months ended June 30, 2019, revenuesMarch 31, 2021 and 2020, respectively. Revenue from one customer accountedcustomers in the United States was $13,837 and $12,923 for 30% of total revenues with no other single customer accounting for more than 10% of revenues. For the ninesix months ended June 30, 2019, revenues from two customers accounted for 43%March 31, 2021 and 11% of total revenues with no other single customer accounting for more than 10% of revenues. As of June 30, 2019, accounts receivable from three customers accounted for 30%, 14% and 11% of total accounts receivable, with no other single customer accounting for more than 10% of the accounts receivable balance.

2020, respectively. The following table summarizes revenues by geographic region. Revenues are attributed to countries based on customer’s delivery location.

 

 

Three months ended June 30,

  

Nine months ended June 30,

  

Three months ended March 31,

  

Six months ended March 31,

 
 

2020

  

2019

  

2020

  

2019

  

2021

  

2020

  

2021

  

2020

 

Americas

 $9,961,591  $5,661,496  $23,871,805  $23,430,521  $8,598  $7,046  $14,406  $13,850 

Asia Pacific

  947,759   2,681,229   3,128,822   3,827,716   2,213   656   3,223   2,204 

Europe, Middle East and Africa

  1,061,746   521,001   2,028,944   1,974,739   490   574   1,700   1,004 

Total Revenues

 $11,971,096  $8,863,726  $29,029,571  $29,232,976  $11,301  $8,276  $19,329  $17,058 

20. SUBSEQUENT EVENT

On August 9, 2020, the Company entered into an Asset Purchase Agreement (the “Purchase Agreement”) to acquire all of the assets of Amika Mobile Corporation (“Amika”). Amika is a leading provider of integrated emergency critical communications based in Ottawa, Canada. The Company intends to fund the proposed acquisition with available cash on hand and in common stock that will be issued ratably on the first, second and third anniversary of the closing date. The closing of the transaction is subject to satisfaction of customary closing conditions, including regulatory review. The Company is in the initial stages of determining the accounting treatment for the transaction, specifically related to the fair value of acquired intangible assets, liabilities, and the related tax impact.

 

2224

 

 

Item 

Item2.Managements Discussion and Analysis of Financial Condition and Results of Operations

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The discussion and analysis set forth below should be read in conjunction with the accompanying unaudited condensed consolidated financial statements and the related notes included under Item 1 of this Quarterly Report on Form 10-Q, together with Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the year ended September 30, 2019.2020.

 

Forward Looking Statements

 

This report contains certain statements of a forward-looking nature relating to future events or future performance. Words such as “expects,expects, “anticipates,anticipates, “intends,intends, “plans,plans, “believes,believes, “seeks,seeks, “estimates”estimates and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the only means of identifying forward-looking statements. Prospective investors are cautioned that such statements are only predictions and- actual events or results may differ materially. In evaluating such statements, prospective investors should specifically consider various factors identified in this report and any matters set forth under Part I, Item1A (Risk Factors) of our Annual Report on Form 10-K, and as noted Part II, Item 1A (Risk Factors) below, which could cause actual results to differ materially from those indicated by such forward-looking statements.

 

Overview

On October 23, 2019, LRAD Corporation announced its rebranding as Genasys Inc. (“Genasys”). Genasys is a global provider of critical communications hardware and software solutions designed to help keep people safe.  Our unified mass notification platform providesencompasses a multi-channel approach to deliver alerts, notifications, instructions, and information before, during, and after public safety and enterprise threats, critical business events, and other crisis situations.

 

Our multi-channel approach includes:

 

LRAD® (Long Range Acoustic Device®), systems that projectthe world’s leading Acoustic Hailing Device (“AHD”), projects sirens and audible voice messages with exceptional vocal clarity in a 30° beam from close range out to 5,500 meters;meters.

 

CCaaS (Critical Communications as a Service)GEM (Genasys Emergency Management) is our unified software platform for cloud, on-premise or hybrid operations that provides a reliable, fastsupports 2-way communications and intuitive solution for sending SMS, text, email and social media messagesseamlessly integrates with physical systems to mobile devicesinitiate life-safety actions in defined geographic areas, and;areas. GEM receives and manages simultaneous inputs from panic buttons, government agency or weather alert feeds, sensor events from digital thermometers, access control, fire panels, camera systems, and more. Using the information derived from the inputs, GEM delivers alerts and notifications on multiple channels, including SMS, MMS, desktop, laptop, tablet and smartphone pop-ups, social media, VoIP, callouts, public address, overhead displays, digital signs, tickers, RSS feeds, and email on any platform.

 

Integrated Solutions Mass Notification Systems (that IMNS) span multiple hardware and software mobile notification channels.channels to reach at risk individuals and populations. These solutionssystems include the Company’s proprietary speakerGenasys voice arrays, which project sirens and audible voice messages 60° - 360° directionally with industry-leading vocal clarity from close range to more than 14 square kilometers, and area coverage, and CCaaSGEM software designed to deliver SMS, text, email, and social media alerts to mobile devicespeople at risk in defined geographic areas. Our integratedIMNS solutions are compatible with the Federal Emergency Management Agency’sAgency (“FEMA”) Integrated Public Alert & Warning System (“IPAWS”) and other major emergency warning protocols.

 

The Company’s critical communication systems are being used in 72 countries throughout the world in a range of diverse applications, including public safety, emergency warning, mass notification, defense, law enforcement, critical event management, and many more. We continue to develop new communication innovations and believe we have significant competitive advantages in our principal markets.

 

LRAD systems arerepresent a technological breakthrough in broadcasting audible, highly intelligible voice messages and tones over long distances and high ambient noise using minimal power. By broadcasting audible voice messages with exceptional vocal clarity and only where needed, we offer novel sound applications that conventional bullhorns, loudspeakers, public address, and emergency warning systems cannot achieve. Our LRAD systems are designed to enable users to safely hail and warn, inform and direct, prevent misunderstandings, determine intent, establish large safety zones, resolve uncertain situations, and save lives. The LRAD product line is comprised of a full range of acoustic hailing devices (“AHD”)AHDs and communication solutions - from handheld, portable devices to permanently installed, remotely operated systems. We continue to expand into new markets and add new models and features to meet customer requirements.

 

Building on the success of our LRAD systems, we designed and developed our multidirectional Genasys mass notification product line. Unlike siren-only installations, our public safety mass notification (“PSMN”)hardware systems broadcast both emergency warning sirens and highly intelligible voice messages with uniform 60° - 360° coverage over local and wide areas. We believe our ability to shape the broadcast coverage area, our industry-leading speech intelligibility, and our multiple system activation and control options enable us to successfully compete in the large and growing mass notification market.

 

25

CCaaS

GEM is a cloud-based mobileour cloud, on-premise or hybrid based software notification platform that enables emergency personnel, first responders, municipalities, companies, and educational institutions, and government agencies to send public safety warnings and notifications to the mobile phonesdevices and desktop computers of crisis-affectedindividuals or populations in specific geographic areas with reliability, speed and ease. Alerts and notifications can be sent from a desktop or our mobile application.applications.

23

 

Genasys offers the only unified critical communications platform that provides multi-modal, geo-targeted mobile phonedevice alerts and speaker arrays that deliverbroadcast audible messages with industry-leading vocal clarity and area coverage. Our user-friendly software interface and mobile application manages and deliverdelivers notifications and information to people at risk, before, during, and after crisis situations.

 

Business developments in the fiscal quarter ended June 30, 2020:March 31, 2021:

 

Announced $14.5 million in U.S. Army follow-on orders

Opened international offices in Dubai and Singapore as part of planned regional expansion

 

Received $4.3 million U.S. Navy IDIQ contract

Awarded software services contract from Spain's Ministry of the Interior

 

Donated Personal Safety Service module to help unify the Salvation Army Western Territory’s COVID-19 response

Announced Government of Canada COVID vaccination tracking software project

 

Announced $3.9 million in international naval, border, port and homeland security orders

Received multi-year enterprise software services contract from global automobile manufacturer for its operations in North America

 

Became an official IPAWS-OPEN software service provider

Signed a $10 million revolving line of credit with MUFG Union Bank, N.A.

Announced and hosted webinar outlining the Company’s National Emergency Warning System (“NEWS”) solution for the European Emergency Warning directive (EECC, Article 110)

 

On August 9, 2020,Revenues in the Company entered intosecond fiscal quarter ended March 31, 2021, were $11.3 million, an Asset Purchase Agreement (the “Purchase Agreement”)increase from $8.3 million in the second fiscal quarter of 2020. The increase in revenues was driven by increases of AHD, IMNS and software revenues. AHD revenue was $9,797, an increase of $2,505 or 34%, IMNS revenue was $826, an increase of $255 or 45%, and software revenue of $676, an increase of $262 or 63%, compared to acquire allthe second fiscal quarter of 2020. Based on the timing of government budget cycles, financial issues, the impact of the assets of Amika Mobile Corporation (“Amika”). Amika is a leading provider of integrated emergency critical communications basedCOVID-19 pandemic and leadership change in Ottawa, Canada. The Company intends to fund the proposed acquisition with available cash on hand and in common stock that will be issued ratably on the first, second and third anniversarycertain areas of the closing date. The closing ofworld, delays in awarding contracts often occur, resulting in uneven quarterly revenues. Gross profit increased compared to the transaction is subject to satisfaction of customary closing conditions, including regulatory review. The Company issame quarter in the initial stagesprior year primarily as a result of determininghigher sales. Operating expenses increased 30% from the accounting treatmentprior year quarter, from $3.7 million to $4.8 million in the quarter ended March 31, 2021. The second fiscal quarter of 2021 results reflect $283 of income tax expense, compared to $97 in the prior year quarter. We reported net income of $262 for the transaction, specifically relatedquarter, or $0.01 per share, compared to net income of $302, or $0.01 per share, for the fair value of acquired intangible assets, liabilities, andsame quarter in the related tax impact.prior year.

 

Overall Business Outlook

 

Our product line-up continues to gain worldwide awareness and recognition through media exposure, product demonstrations, and word of mouth as a result of positive responses and increased acceptance of our products. We believe we have a solid global brand, technology, and product foundation with our LRAD systems and integratedIMNS solutions, which we have expanded over the years to serve new markets and customers for greater business growth.  We believe that we have strong market opportunities for our product offerings throughout the world in the defense, public safety, emergency warning, mass notification, critical event managementhomeland security and law enforcementdefense sectors as a result of increasing threats to government, commerce, law enforcement, homeland securityborders, and critical infrastructure. Our directional and multidirectional product offerings also have many applications within the fire rescue, public safety, maritime, asset protection, and wildlife control and preservation business segments.

 

The proliferation of natural disasters, crisis situations, and civil disturbancesunrest require technologically advanced, multi-channel solutions to deliver clear and timely critical communications to help keep people safe.the public safe during emergencies. Businesses are also incorporating communication systems that locate and help safeguard employees when critical events occur.

 

By providing the only unified platform that combines audible, highly intelligible voice broadcast systems and CCaaSmass messaging software, Genasys seeks to deliver reliable, fast, and intuitive solutionsolutions for sending location-based audible voice communications and geolocation-targeted messages and texts to mobile devices to help keep the public and employeesworkers safe.

 

Genasys has developed a global market for LRAD systems and advanced emergency warning notification solutions. We have a reputation for producing quality products that feature industry-leading vocal intelligibility and geo-targeted mass messaging. While the mass notification market is more mature with many established manufacturers and suppliers, we believe that our advanced technology and unified multi-channel platform provides opportunities to succeed in the large and growing public safety, emergency warning, and mass notification markets. We also plan to expand and strengthen domestic and international sales channels by opening additional sales offices in key regions and adding keystrategic mass notification partners, distributors, and dealers.

 

We plan to continue building on our AHD leadership position by offering enhanced directional and multidirectional voice broadcast systems and accessories for an expanding range of applications. In executing our strategy, we use direct sales to governments, militaries, large end-users, and system integrators. We have built a worldwide distribution channel consisting of partners and resellers that have significant expertise and experience selling integrated communication solutions into our various target markets. As our primary AHD sales opportunities are with domestic and international government, military, and law enforcement agencies, we are subject to each customer’s unique budget cycle, which leads to long selling cycles and uneven revenue flow, complicating our product planning. 

 

2426

 

In fiscal 2020,2021, we intend to continue pursuingto pursue domestic and international business opportunities with the support of business development consultants, key representatives, and resellers. We plan to grow our revenues through increased direct sales to militaries and large commercial and defense-related companies that desire to integrate our communication technologies into their product offerings. This includes building on our fiscal 20192020 domestic defense sales by pursuing further U.S. military opportunities. We also plan to pursue mass notification, government, law enforcement, fire rescue, homeland and international security, private and commercial security, border security, maritime security, and wildlife preservation and control business opportunities. In addition to the matters above, we are authorized for the performance of services and provision of goods pursuant to Delaware General Corporation Law.

 

In March 2020, the World Health Organization ("WHO") classified the COVID-19 outbreak as a pandemic. While the impact of the COVID-19 pandemic did not have a material adverse effect on our financial position or results of operations for the quarterthree months ended June 30, 2020,March 31, 2021, we have been monitoringmonitor the developments and assessingassess areas where there is potential for our business to be impacted. A significant portion of our sales force is working remotely, which could, among other things, negatively impact our ability to engage in sales-related initiatives, or efficiently conduct day-to-day operations. Other businesses and governments with which we engage are likely operating under similar restrictions and experiencing disruptions, which may create obstacles in the coordination of business activities, including the negotiation and fulfillment of orders. Disruptions in the supply chain could negatively impact our ability to source materials or manufacture and distribute products. While we do not currently anticipate a material reduction in demand for our commercialized products, we could experience a decrease in new orders, which wouldcould negatively impact our revenues and reduce our liquidity and cash flows. Growth in revenue could also be impeded by these factors. The financial markets have been subject to significant volatility that could impact our ability to enter into, modify, and negotiate favorable terms and conditions relative to equity and debt financing activities. We currently have $20.7$18.5 million in cash and cash equivalents as of June 30, 2020,March 31, 2021, which we believe provides sufficient capital to fund our operations for at least the next twelve months and withstand the anticipatedpotential near-term consequences of the pandemic, although liquidity constraints and access to capital markets could adversely impact our liquidity and warrant changes to our investment strategy. While we have not yet experienced a material impact, the full magnitude of the pandemic cannot be measured at this time, and therefore, any of the aforementioned circumstances, as well as other factors, may cause our results of operations to vary substantially from year to year and quarter to quarter.

The large majority of components and sub-assemblies in our supply chain are sourced from outside vendors located within 50 miles of our facility. We source a small number of component parts from suppliers in China. It is also likely that some of our suppliers source parts from China. We are in contact with those suppliers and evaluating what impact, if any, may result from the coronavirus pandemic.

 

Based on various standards published to date, we believe the work our associates perform is critical, essential and life sustaining. We are taking a variety of measures to promote the safety and security of our employees while ensuring the availability and functionality of our critical infrastructure. We are following Center for Disease Control guidelines to reduce the transmission of COVID-19, such as the imposition of travel restrictions, cancellation of events, the promotion of social distancing, the adoption of work-from-home arrangements, and limiting access to our facilities. Some or all of these policies and initiatives could impact our operations. In addition, the following events related to the COVID-19 pandemic could result in lost or delayed revenue to the Company: limitations on the ability of our suppliers to meet delivery requirements and commitments; limitations on the ability of our employees to perform their work due to illness caused by the pandemic, or local, state or federal orders requiring employees to remain at home; limitations on the ability of carriers to deliver our products to customers; unforeseen deviations from customers or foreign governments restricting the ability to do business; and, limitations on the ability of our customers to pay us on a timely basis, if at all.

A large number of components and sub-assemblies produced by outside suppliers within our supply chain are produced within 50 miles of our facility. We source a small amount of component parts from suppliers in China. It is also likely that some of our suppliers source parts in China. The COVID-19 pandemic has adversely impacted worldwide supply chains and the ability to obtain sufficient amounts of component parts, including semiconductor chips and integrated circuits, resins, coating and other equipment and components. Negative impacts on our supply change could have a material adverse effect on our business. We are in contact with our suppliers and evaluating what impact, if any, may result from COVID-19.

 

Critical Accounting Policies

 

We have identified a number of accounting policies as critical to our business operations and the understanding of our results of operations. These are described in our consolidated financial statements located in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended September 30, 2019.2020. The impact and any associated risks related to these policies on our business operations is discussed below and throughout Management’s Discussion and Analysis of Financial Condition and Results of Operations when such policies affect our reported and expected financial results.

 

The methods, estimates and judgments we use in applying our accounting policies, in conformity with U.S. generally accepted accounting principles, have a significant impact on the results we report in our financial statements. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. The estimates affect the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions.

 

2527

 

Comparison of Results of Operations for the ThreeThree Months Ended June 30,March 31, 2021 and 2020 and 2019 (in thousands)

 

 

Three Months Ended

          

Three Months Ended

         
 

June 30, 2020

  

June 30, 2019

          

March 31, 2021

  

March 31, 2020

         
     

% of

      

% of

              

% of

      

% of

         
     

Total

      

Total

  

Fav(Unfav)

      

Total

      

Total

  

Fav(Unfav)

 
 

Amount

  

Revenue

  

Amount

  

Revenue

  

Amount

  

%

  

Amount

  

Revenue

  

Amount

  

Revenue

  

Amount

  

%

 

Revenues

                        

Revenues:

                        

Product sales

 $10,932,719   91.3%  $8,037,460   90.7%  $2,895,259   36.0%  $10,131   89.6% $7,553   91.3% $2,578   34.1%

Contract and other

  1,038,377   8.7%   826,266   9.3%   212,111   25.7%   1,170   10.4%  723   8.7%  447   61.8%

Total revenues

  11,971,096   100.0%   8,863,726   100.0%   3,107,370   35.1%   11,301   100.0%  8,276   100.0%  3,025   36.6%
                                                

Cost of revenues

  5,499,914   45.9%   4,261,733   48.1%   (1,238,181)  (29.1%)   5,964   52.8%  4,266   51.5%  (1,698)  (39.8%)

Gross Profit

  6,471,182   54.1%   4,601,993   51.9%   1,869,189   40.6%   5,337   47.2%  4,010   48.5%  1,327   33.1%
                                                

Operating expenses

                                                

Selling, general and administrative

  3,330,365   27.8%   2,712,846   30.6%   (617,519)  (22.8%)   3,824   33.8%  2,732   33.0%  (1,092)  (40.0%)

Research and development

  1,199,635   10.0%   1,202,686   13.6%   3,051   0.3%   960   8.5%  949   11.5%  (11)  (1.2%)

Total operating expenses

  4,530,000   37.8%   3,915,532   44.2%   (614,468)  (15.7%)   4,784   42.3%  3,681   44.5%  (1,103)  (30.0%)
                                                

Income from operations

  1,941,182   16.2%   686,461   7.7%   1,254,721   182.8%   553   4.9%  329   4.0%  224   68.1%
                                                

Other income

  36,227   0.3%   69,890   0.8%   (33,663)  (48.2%) 

Other income (expense)

  (8)  (0.1%)  70   0.8%  (78)  (111.4%)
                                                

Income before income taxes

  1,977,409   16.5%   756,351   8.5%   1,221,058   161.4%   545   4.8%  399   4.8%  146   36.6%

Income tax expense

  473,332   4.0%   118,310   1.3%   (355,022)  (300.1%)   283   2.5%  97   1.2%  (186)  (191.8%)

Net income

 $1,504,077   12.6%  $638,041   7.2%  $866,036   135.7%  $262   2.3% $302   3.6% $(40)  (13.2%)
                                                

Net Revenue

                        

Net revenue

                        

Hardware

 $11,604,345   96.9%  $8,302,811   93.7%   3,301,534   39.8%  $10,625   94.0% $7,862   95.0%  2,763   35.1%

Software

  366,751   3.1%   560,915   6.3%   (194,164)  (34.6%)   676   6.0%  414   5.0%  262   63.3%

Total net revenue

 $11,971,096   100.0%  $8,863,726   100.0%  $3,107,370   35.1%  $11,301   100.0% $8,276   100.0% $3,025   36.6%

 

The tabletables above setsset forth for the periods indicated certain items of our condensed consolidated statements of operations expressed in dollars and as a percentage of net revenues. The financial information and the discussion below should be read in conjunction with the condensed consolidated financial statements and notes contained in this report.

 

Revenues

 

Revenues increased in the current quarter compared to the same quarter in the prior year primarily due to the timing of deliveries in backlog as of MarchDecember 31, 2020, as compared to MarchDecember 31, 2019. Current year quarter LRAD AHD product line revenue was $10,464,308, an increase of $5,586,728 compared to the same prior year period. PSMN systems product line$9,797, up $2,505 or 34%, IMNS revenue was $1,506,788, down $2,479,358$826, up $255 or 45%, and software revenue was $676, up $262 or 63%, compared to the same prior year period. The receipt of orders is often uneven due to the timing of government budgets or approvals. The increase in software revenue in this year’s period is primarily from professional services revenue on new software contracts. As of June 30, 2020,March 31, 2021, we had aggregate deferred revenue of $915,083$834 for extended warranty obligations and software support agreements.

 

Gross Profit

 

The increase in gross profit in the quarter compared to the same period in the prior year was primarily due to the higher level of revenue. Gross profit as a percentage of revenue was higherlower in the fiscal 2020 third2021 second quarter due to higher revenuea 56% increase in the period, which further leveraged our fixed operating costs.

Our products have varying gross margins, so product mix may affect gross profits. In addition, our margins vary based on the sales channels through which our products are sold in a given period. We continue to implement product updates and changes, including raw material and component changes that may impact product costs. With such product updates and changes we have limited warranty cost experience and estimated future warranty costs can impact our gross margins. We do not believe that historical gross profit margins should be relied upon as an indicator of future gross profit margins.

26

Selling, General and Administrative Expenses

Selling, general and administrativeengineering personnel, primarily software related. Higher software expenses increased $617,519 over the prior year quarterwere due primarily due to increased spending for compensation related expenditures ($552,611) and professional services ($271,947) offset by lower travel related expenses ($129,849).

We incurred non-cash share-based compensation expenses allocated to selling, general and administrative expenses in the three-months ended June 30, 2020 and 2019 of $310,997 and $242,660, respectively.

We expect increased spending on the marketing and selling of our products in future periods as we identify ways to optimize potential opportunities, including the June 2022 European Union Public Warning Systems Mandate (European Electronic Communications Code, Article 110). Commission expenses will fluctuate based on the nature of our sales.

Research and Development Expenses

Research and development expenses decreased $3,051 compared to the same quarter in the prior year primarily due to the allocation of $160,000 of engineering expenses to cost of revenues and lower development material costs ($48,277), offset by higher compensation related expenses ($193,604) due to an increase of eight engineers this year. We continue to expand our software development efforts to grow our emergency warning solutions product offerings.

Included in research and development expenses for the three months ended June 30, 2020 and 2019, was $6,167 and $11,279, respectively, of non-cash share-based compensation costs.

Research and development costs vary period to period due to the timing of projects, and the timing and use of outside consulting, design and development firms. We continually improve our product offerings and we expect to continue expanding our product line with new products, customizations and enhancements. Based on current plans, we may expend additional resources on research and development in the current year compared to the prior year.

Net Income

Net income in the third quarter of fiscal year 2020 was $1,504,077, an increase of $866,036 compared to the third quarter of fiscal year 2019. The increase was primarily due to higher revenue offset by increased selling, general and administrative expenses in the third quarter of fiscal year 2020.

27

Comparison of Results of Operations for the Nine Months Ended June 30, 2020 and 2019

  

Nine Months Ended

         
  

June 30, 2020

  

June 30, 2019

         
      

% of

      

% of

         
      

Total

      

Total

  

Fav(Unfav)

 
  

Amount

  

Revenue

  

Amount

  

Revenue

  

Amount

  

%

 

Revenues

                        

Product sales

 $26,494,138   91.3%  $26,726,151   91.4%  $(232,013)  (0.9%) 

Contract and other

  2,535,433   8.7%   2,506,825   8.6%   28,608   1.1% 

Total revenues

  29,029,571   100.0%   29,232,976   100.0%   (203,405)  (0.7%) 
                         

Cost of revenues

  13,946,392   48.0%   14,351,217   49.1%   404,825   2.8% 

Gross Profit

  15,083,179   52.0%   14,881,759   50.9%   201,420   1.4% 
                         

Operating expenses

                        

Selling, general and administrative

  8,884,230   30.6%   7,939,232   27.2%   (944,998)  (11.9%) 

Research and development

  3,232,369   11.1%   3,530,805   12.1%   298,436   8.5% 

Total operating expenses

  12,116,599   41.7%   11,470,037   39.2%   (646,562)  (5.6%) 
                         

Income from operations

  2,966,580   10.2%   3,411,722   11.7%   (445,142)  (13.0%) 
                         

Other income

  201,889   0.7%   126,566   0.4%   75,323   59.5% 
                         

Income before income taxes

  3,168,469   10.9%   3,538,288   12.1%   (369,819)  (10.5%) 

Income tax expense

  742,490   2.6%   675,457   2.3%   (67,033)  (9.9%) 

Net income

 $2,425,979   8.4%  $2,862,831   9.8%  $(436,852)  (15.3%) 
                         

Net revenue

                        

Hardware

 $27,832,550   95.9%  $27,606,026   94.4%   226,524   0.8% 

Software

  1,197,021   4.1%   1,626,950   5.6%   (429,929)  (26.4%) 

Total net revenue

 $29,029,571   100.0%  $29,232,976   100.0%  $(203,405)  (0.7%) 

The table above sets forth for the periods indicated certain items of our condensed consolidated statements of operations expressed in dollars and as a percentage of net revenues. The financial information and the discussion below should be read in conjunction with the condensed consolidated financial statements and notes contained in this report.

Revenues

Revenues decreased 1% for the nine-month period ended June 30, 2020 compared to the same prior year period due to the timing for deliveryrecent addition of the backlog at March 31, 2020 comparedAmika Mobile business (through our Genasys Communication Canada subsidiary), and additional employees to support the March 31, 2019 backlog. LRAD AHD product line revenues were $25,511,247 for the current year nine-month period, an increase of $2,877,540,Australia, EU and PSMN revenues were $3,518,324, down $3,080,945, compared to the same prior year period. The receipt of orders will often be uneven due to the timing of government budgets and approvals. As of June 30, 2020, we had aggregate deferred revenue of $915,083 for extended warranty obligations andenterprise software support agreements.

Gross Profit

The increase in gross profit in the nine months ended June 30, 2020 was primarily due to a better mix of revenue offset by $271,000 of additional engineering charges resulting from a more precise process to charge engineering costs to cost of revenue. Gross profit as a percentage of revenue increased 1% compared to the prior year period.initiatives.

 

Our products have varying gross margins, so product mix may affect gross profits. In addition, our margins vary based on the sales channels through which our products are sold in a given period. We continue to implement product updates and changes, including raw material and component changes that may impact product costs. With such product updates and changes we have limited warranty cost experience and estimated future warranty costs can impact our gross margins. We do not believe that historical gross profit margins should be relied upon as an indicator of future gross profit margins.

 

28

 

Selling, General and Administrative Expenses

 

Selling, general and administrative expenses increased $944,998 in the nine months ended June 30, 2020 compared to$1,092, or 40%, over the prior year period. The increase in selling, general and administrative expenses isquarter primarily due to compensation related expenses ($606,681), professional services ($348,163), anda 67% increase in sales and marketing activities ($203,349)personnel over the prior year to support future revenue growth opportunities, including opening sales offices in Singapore and the United Arab Emirates. This was partially offset by lower travel ($129,358) and computer and software relatedmarketing expenses ($100,150).resulting from the COVID-19 pandemic.

 

We incurred non-cash share-based compensation expenses allocated to selling, general and administrative expenses in the nine monthsthree-months ended June 30,March 31, 2021 and 2020 of $309 and 2019 of $738,238 and $508,761,$283, respectively.

 

We may expend additional resources on the marketing and selling of our products in future periods as we identify ways to optimize potential opportunities, including the June 2022 European Mandate for Public Warning Systems and enterprise software services. Commission expenses will fluctuate based on the nature of our sales.

Research and Development Expenses

Research and development expenses decreased $11, essentially unchanged compared to the same quarter in the prior year.

Included in research and development expenses for the three months ended March 31, 2021 and 2020, was $10 and $6, respectively, of non-cash share-based compensation costs.

Research and development costs vary period to period due to the timing of development projects, amount of support provided on customer projects, and the timing and use of outside consulting, design and development firms. We continually improve our product offerings, and we expect to continue to expand our product line with new products, customizations and enhancements. Based on current plans, we may expend additional resources on research and development in the current year compared to the prior year.

Net Loss/Income

Net income in the second quarter of fiscal year 2021 was $262, a decrease of $40 compared to the second quarter of fiscal year 2020. The decrease was primarily due to increased selling, general and administrative expenses offsetting the increased revenue in the second quarter of fiscal year 2021.

29

Comparison of Results of Operations for the Six Months Ended March 31, 2021 and 2020 (in thousands)

  

Six Months Ended

         
  

March 31, 2021

  

March 31, 2020

         
      

% of

      

% of

         
      

Total

      

Total

  

Fav(Unfav)

 
  

Amount

  

Revenue

  

Amount

  

Revenue

  

Amount

  

%

 

Revenues:

                        

Product sales

 $17,081   88.4% $15,561   91.2% $1,520   9.8%

Contract and other

  2,248   11.6%  1,497   8.8%  751   50.2%

Total revenues

  19,329   100.0%  17,058   100.0%  2,271   13.3%
                         

Cost of revenues

  10,288   53.2%  8,446   49.5%  (1,842)  (21.8%)

Gross Profit

  9,041   46.8%  8,612   50.5%  429   5.0%
                         

Operating expenses

                        

Selling, general and administrative

  7,155   37.0%  5,554   32.6%  (1,601)  (28.8%)

Research and development

  2,026   10.5%  2,033   11.9%  7   0.3%

Total operating expenses

  9,181   47.5%  7,587   44.5%  (1,594)  (21.0%)
                         

Income (loss) from operations

  (140)  (0.7%)  1,025   6.0%  (1,165)  (113.7%)
                         

Other income

  61   0.3%  166   1.0%  (105)  (63.3%)
                         

(Loss) income before income taxes

  (79)  (0.4%)  1,191   7.0%  (1,270)  (106.6%)

Income tax expense (benefit)

  278   1.4%  269   1.6%  (9)  (3.3%)

Net (loss) income

 $(357)  (1.8%) $922   5.4% $(1,279)  (138.7%)
                         

Net revenue

                        

Hardware

 $18,012   93.2% $16,221   95.1%  1,791   11.0%

Software

  1,317   6.8%  837   4.9%  480   57.3%

Total net revenue

 $19,329   100.0% $17,058   100.0% $2,271   13.3%

The tables above set forth for the periods indicated certain items of our condensed consolidated statements of operations expressed in dollars and as a percentage of net revenues. The financial information and the discussion below should be read in conjunction with the condensed consolidated financial statements and notes contained in this report.

Revenues

Revenues increased 13% for the six-months ended March 31, 2021 compared to the same prior year period primarily due to the timing for delivery of the backlog at September 30, 2020 compared to the September 30, 2019 backlog. AHD revenue was $16,866 for the current year six-month period, up $1,826, or 12%, IMNS revenue was $1,144, down $37, or 3%, and software revenue was $1,317, up $480 or 57% compared to the same prior year period. The receipt of orders will often be uneven due to the timing of approvals or budgets. As of March 31, 2021, we had aggregate deferred revenue of $834 for extended warranty obligations and software support agreements.

Gross Profit

The increase spendingin gross profit in the six months ended March 31, 2021 was primarily due to higher sales volume. Gross profit as a percentage of revenue was lower compared to the prior year period primarily due to an 82% increase in software engineering personnel over last year. Higher software expenses were due primarily to the recent addition of Amika Mobile (through our Genasys Communications Canada subsidiary), and additional employees to support the Australia, EU and enterprise software initiatives.

Our products have varying gross margins, so product mix may affect gross profits. In addition, our margins vary based on the sales channels through which our products are sold in a given period. We continue to implement product updates and changes, including raw material and component changes that may impact product costs. With such product updates and changes we have limited warranty cost experience and estimated future warranty costs can impact our gross margins. We do not believe that historical gross profit margins should be relied upon as an indicator of future gross profit margins.

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased $1,601 or 29%, in the six months ended March 31, 2021 compared to the prior year period. The increase in selling, general and administrative expenses was primarily due to a 67% increase in sales and marketing personnel over the prior year to support future revenue growth opportunities. This was partially offset by lower travel and marketing expenses resulting from the COVID-19 pandemic.

30

We incurred non-cash share-based compensation expenses allocated to selling, general and administrative expenses in the six months ended March 31, 2021 and 2020 of $479 and $427, respectively.

We may expend additional resources on the marketing and selling of our products in future periods as we identify ways to optimize potential opportunities. Commission expenses will fluctuate based on the nature of our sales.

 

Research and Development Expenses

 

Research and development expenses decreased $298,436$7, essentially unchanged compared to the prior year primarily due to engineering expenses charged to cost of revenues ($242,729) and lower prototype costs ($143,012) partially offset by higher compensation related expenses ($135,031) from increased staffing.period.

 

Included in research and development expenses for both of the ninesix months ended June 30,March 31, 2021 and 2020 and 2019 were $21,992 and $42,499$16 of non-cash share-based compensation costs, respectively.costs.

 

Research and development costs vary period to period due to the timing of projects, amount of support provided on customer projects, and the timing and use of outside consulting, design, and development firms. We continually improve our product offerings, and we expect to continue expandingto expand our product line in 2020 with new products, customizations, and enhancements. Based on current plans, we may expend additional resources on research and development in the current year compared to the prior year.

 

Net Loss/Income

 

Net incomeloss of $2,425,979$357 for the ninefirst six months year to date inof fiscal year 20202021 was a decrease of $436,852$1,279 compared to the $922 of net income in the comparative prior year period. This decrease was primarily due to the higher operating expenses, partially offset by the higher revenue, in the current year to date period.

 

Liquidity and Capital Resources

 

The Company’s financial condition and liquidity remain strong. Cash and cash equivalents at June 30, 2020March 31, 2021 was $20,667,934, an increase of $1,848,856$18,455, down $4,864 compared to $18,819,078$23,319 at September 30, 2019.2020. We had short-term marketable securities of $4,054,126$5,474 at June 30, 2020,March 31, 2021, compared to $3,695,364$4,265 at September 30, 2019.2020. We had long-term marketable securities of $3,336,654$2,450 at June 30, 2020,March 31, 2021, compared to $1,384,819$3,805 at September 30, 2019.2020. In addition, we have a $10 million line of credit with MUFG Bank, N.A. At March 31, 2021, the Company had no outstanding balance against the line of credit. The credit agreement requires the Company to comply with various financial and operating covenants and at March 31, 2021, the Company was in compliance with these covenants. Other than cash and cash equivalents, short and long-term marketable securities, other working capital, and expected future cash flows from operating activities in subsequent periods and the line of credit, we have no unused sources of liquidity at this time.

 

Although there is uncertainty related to the anticipated impact of the COVID-19 outbreak on the Company’s future results, we believe our efficient business model and strong balance sheet have us positioned to manage our business through this crisis as it continues to unfold. We continue to manage all aspects of our business including, but not limited to, monitoring the financial health of our customers, suppliers and other third-party relationships and developing new opportunities for growth.

Principal factors that could affect our liquidity include:

 

ability to meet sales projections;

government spending levels;

introduction of competing technologies;

product mix and effect on margins;

ability to reduce current inventory levels;

product acceptance in new markets;

value of shares repurchased;

value of dividends declared;

impact of COVID-19 on global market conditions; and

ability to meet sales projections;

government spending levels;

introduction of competing technologies;

product mix and effect on margins;

ability to reduce current inventory levels;

product acceptance in new markets;

value of shares repurchased;

value of dividends declared;

impact of COVID-19 on global market conditions; and

impact of COVID-19 on customers’ ability to pay.

29

 

Principal factors that could affect our ability to obtain cash from external sources include:

 

volatility in the capital markets; and

market price and trading volume of our common stock.

volatility in the capital markets; and

market price and trading volume of our common stock.

 

Based on our current cash position, and assuming currently planned expenditures and level of operations, we believe we have sufficient capital to fund operations for the twelve-month period subsequent to the issuance of the interim financial information. However, we operate in a rapidly evolving and unpredictable business environment that may change the timing or amount of expected future cash receipts and expenditures. Accordingly, there can be no assurance that we may not be required to raise additional funds through the sale of equity or debt securities or from credit facilities. Additional capital, if needed, may not be available on satisfactory terms, or at all.

 

31

Cash Flows

 

Our cash flows from operating, investing and financing activities, as reflected in the condensed consolidated statements of cash flows, are summarized in the table below:

 

 

Nine months ended

  

Six months ended

 
 

June 30, 2020

  

June 30, 2019

  

March 31, 2021

  

March 31, 2020

 

Cash provided by (used in):

                

Operating activities

 $3,710,590  $2,413,334  $363  $(2,127)

Investing activities

  (2,425,264)  29,759   (4,375)  (144)

Financing activities

  540,525   (2,133,445)  (27)  (198)

 

Operating Activities

 

Net loss of $357 for the six months ended March 31, 2021 was offset by $1,864 of non-cash items that included depreciation and amortization, share-based compensation, operating ROU asset amortization, warranty provision, inventory obsolescence, both realized and unrealized loss on a foreign currency forward contract and a reduction to deferred income taxes. Cash used in operating activities for the current year reflected a decrease in accrued and other liabilities of $1,363, primarily for a $514 decrease in customer deposits resulting from shipments for the year to date and $491 of net lower accrued payroll and related liabilities, an increase of $698 in inventory to support the current backlog, a $253 increase in prepaid expenses and an increase in accounts receivable of $14. Cash provided by operating activities included an increase in accounts payable of $1,184, primarily for inventory related purchases.

Net income of $2,425.979$922 for the ninesix months ended June 30,March 31, 2020 was increased by $2,754,542$1,547 of non-cash items that included a reduction to deferred income taxes, share-based compensation, depreciation and amortization, warranty provision, amortization of operating right of use assets and inventory obsolescence. Cash used in operating activities at June 30,in the six months ended March 31, 2020 reflected a decrease in accrued and other liabilities of $3,036, primarily for a $1,797 decrease in customer deposits resulting from shipments for the year to date, and $825 lower accrued payroll and related liabilities largely for the payment of incentive compensation earned in fiscal 2019, an increase in accounts receivable of $2,721,719$2,205 due to higher sales with net credit terms in the quarter compared to the fourth quarter of fiscal 2019, and an increase of $1,214 in inventory of $1,667,264 to support the current backlog. Cash provided by operating activities included an increase in accounts payable of $2,039,811 primarily for inventory related purchases, a decrease in prepaid expenses and other of $731,501 and an increase in accrued liabilities of $147,740.

Net income of $2,862,831 for the nine months ended June 30, 2019 was increased by $2,045,884 of non-cash items that included a reduction to deferred income taxes, share-based compensation, depreciation and amortization, warranty provision and inventory obsolescence. Cash provided by operating activities in fiscal 2019 reflected a decrease in prepaid expenses and other of $2,447,870, an increase in accrued and other liabilities of $1,153,067, a decrease in inventory of $200,306 and a decrease in other assets of $116,973. Cash used in operating activities included an increase in accounts receivable of $4,029,608, a decrease in accounts payable of $2,267,016$1,072, primarily for inventory related purchases, and a decrease in payrollprepaid expenses and related liabilitiesother of $583,162.$787.

 

We had accounts receivable of $6,378,357$5,445 as of June 30, 2020,March 31, 2021, compared to $3,644,059$5,442 at September 30, 2019.2020. Terms with individual customers vary greatly. We regularly provide thirty-day terms to our customers if credit is approved. Our receivables can vary dramatically due to overall sales volume, quarterly variations in sales, timing of shipments to and receipts from large customers, payment terms, and the timing of contract payments.

 

As of June 30, 2020March 31, 2021 and September 30, 2019,2020, our working capital was $26,927,851$26,481 and $24,765,178,$29,796, respectively. The increasedecrease in working capital was primarily due to the net income from operations anduse of cash received fromto complete the exercise of stock optionsAmika Mobile asset purchase in the first nine monthsquarter of fiscal year 2020.2021.

 

Investing Activities

 

Our net cash used in investing activities was $2,425,264$4,375 for the ninesix months ended June 30, 2020,March 31, 2021, compared to cash provided byused in investing activities of $29,759$144 for the ninesix months ended June 30, 2019.March 31, 2020. In the first ninesix months of fiscal 2020,2021, $4,367 was used for the Amika Mobile asset purchase. In the first six months of fiscal 2021, we increaseddecreased our holdings of short and long-term marketable securities by $2,310,597,$140, compared to a decreasean increase of $314,442$42 in the ninesix months ended June 30, 2019.March 31, 2020. Cash used in investing activities for the purchase of property and equipment was $111,602$148 and $303,912$102 for the ninesix months ended June 30,March 31, 2021 and 2020, and 2019, respectively. We anticipate additional expenditures for tooling and equipment during the balance of fiscal year 2020.2021.

30

 

Financing Activities

 

In the ninesix months ended June 30, 2020,March 31, 2021, we received $540,525used $27 for financing activities, compared to a use of $2,133,445$198 for financing activities for the ninesix months ended June 30, 2019. ProceedsMarch 31, 2020. In the first six months of fiscal 2021 we received $170 from the exercise of stock options, which was offset by $141 of cash used to settle statutory tax withholding requirements on behalf of our employees upon vesting of restricted stock awards. During the first six months of fiscal 2020, proceeds from the exercise of stock options were $996,891 for the nine months ended June 30, 2020$258 and we used $398,256$398 to repurchase Companycompany common stock. During the first nine months of fiscal 2019 we used $2,171,022 to repurchase shares of common stock offset by $54,621 in proceeds from the exercise of stock options.

The Board of Directors approved a share buyback program in 2015 under which the Company was authorized to repurchase up to $4 million of its outstanding common shares. In December 2017, the Board of Directors extended the program through December 31, 2018, at which time it expired.

 

In December 2018, the Board of Directors approved a new share buyback program beginning January 1, 2019 under which the Company was authorized to repurchase up to $5 million of its outstanding common shares. During the quarter ended June 30, 2020,March 31, 2021, no shares were repurchased. During the quarter ended June 30, 2019, noMarch 31, 2020, 156,505 shares were repurchased.repurchased for $398,255. As of June 30, 2020,March 31, 2021, all repurchased shares were retired. As of June 30, 2020,March 31, 2021, $4.1 million was available for share repurchase under this program. In December 2020, the Board of Directors extended this program’s expiration date to December 31, 2022.

32

 

Recent Accounting Pronouncements

 

New pronouncements issued for future implementation are discussed in Note 3, Recent Accounting Pronouncements, to our condensed consolidated financial statements.

 

Item 

Item3.Quantitative and Qualitative Disclosures about Market Risk.

Quantitative and Qualitative Disclosures about Market Risk.

 

Foreign Currency Risk

We consider our direct exposure to foreign exchange rate fluctuations to be minimal. The transactions of our Spanish subsidiary are denominated primarily in Euros and the transactions of our Canadian subsidiary are denominated primarily in Canadian dollars, which is a natural hedge against foreign currency fluctuations. Currency translation gains and losses are primarily related to our Spanish and Canadian subsidiaries, whereby assets and liabilities are translated from the respective functional currency into U.S. dollars using period-end exchange rates, which impacts other comprehensive income.

All other sales to customers and all arrangements with third-party manufacturers, with one exception, provide for pricing and payment in U.S. dollars, and, therefore, are not subject to exchange rate fluctuations. Increases in the value of the U.S. dollar relative to other currencies could make our products more expensive, which could negatively impact our ability to compete. Conversely, decreases in the value of the U.S. dollar relative to other currencies could result in our suppliers raising their prices to continue doing business with us. Fluctuations in currency exchange rates could affect our business in the future.

 

Item 

Item4.Controls and Procedures.

Controls and Procedures.

 

We are required to maintain disclosure controls and procedures designed to ensure that material information related to us, including our consolidated subsidiaries, is recorded, processed, summarized, and reported within the time periods specified in the SEC rules and forms.

 

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our principal executive officer and our principal financial officer, we conducted an evaluation of our disclosure controls and procedures as such term is defined under Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934. Based on this evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of June 30, 2020.March 31, 2021.

 

Changes in Internal Control over Financial Reporting

 

There have been no changes in our internal control over financial reporting during our fiscal quarter ended June 30, 2020,March 31, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Our process for evaluating controls and procedures is continuous and encompasses constant improvement of the design and effectiveness of established controls and procedures and the remediation of any deficiencies which may be identified during this process.

 

Because of the inherent limitations of internal control over financial reporting, including the possibility of collusion or improper management override of controls, material misstatements due to error or fraud may not be prevented or detected on a timely basis. Also, projections of any evaluation of the effectiveness of the internal control over financial reporting to future periods are subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

31

PART II. OTHER INFORMATION

Item 1.Legal Proceedings.

Legal Proceedings.

 

We may at times be involved in litigation in the ordinary course of business. We will also, from time to time, when appropriate in management’s estimation, record adequate reserves in our consolidated financial statements for pending litigation. Currently, there are no pending material legal proceedings to which the Company is a party or to which any of its property is subject.

 

Item 

Item1A.Risk Factors.

Risk Factors.

 

In additionThere have been no material changes to the other information set forth in this Quarterly Report, you should carefully consider the risks and uncertainties discussed in Part 1, “Itemrisk factors described under Item 1A Risk Factors” inof our Annual Report on Form 10-K for the fiscal year ended September 30, 2019,2020, filed with the SEC on December 10, 2020 except for those noted below:

33

Supply chain disruptions. The COVID-19 pandemic has adversely impacted worldwide supply chains and the ability to obtain sufficient amounts of component parts, including semiconductor chips and integrated circuits, resins, coating and other equipment and components. Negative impacts on our supply change could have a material adverse effect on our business.

Reference rate reform. Borrowings under our credit facility with MUFG Union Bank, N.A. will bear an interest rate based on certain tenors of the London interbank offered rate (“LIBOR”) plus a credit spread. In July 2017, the United Kingdom’s Financial Conduct Authority, which regulates LIBOR, announced that, after 2021, it will stop compelling banks to submit rates for the calculation of LIBOR. The discontinuation, reform, or replacement of LIBOR could materially affect our business, financial condition, or future results. The risks describedresult in our Annual Report on Form 10-K are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be not material also may materially andinterest rate increases, which could adversely affect our business, financial conditioncash flows and operating results. We are including the following additional risk factor, which updates the risk factors disclosed in our Annual Report on Form 10-K for the year ended September 30, 2019. In addition, many of the risk factors in Part 1, Item 1A, Risk Factors, in our Annual Report on Form 10-K for the fiscal year ended September 30, 2019, will be amplified by the following additional risk factor.

 

Global economic conditions related to the COVID-19 pandemic may negatively impact the Company’s financial conditionsItem2.Unregistered Sales of Equity Securities and resultsUse of operations.Proceeds.

The Company is monitoring the impact of the COVID-19 outbreak, which has already caused a significant disruption to global financial markets and supply chains, beginning in early calendar year 2020. The significance of the operational and financial impact to the Company will depend on how long and widespread this disruption proves to be. The extent to which COVID-19 impacts the Company’s results will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of the outbreak and the actions that are being taken to contain and treat it. There is uncertainty around the duration and broader impact of COVID-19 and therefore, the effects it will have on the Company’s financial results and operations. If economic or market conditions in key global markets deteriorate, the Company may experience material adverse effects on its business, financial condition and results from operations.

Factors deriving from the COVID-19 response that may negatively impact sales and gross margin in the future include but are not limited to: limitations on the ability of our suppliers to meet delivery requirements and commitments; limitations on the ability of employees to perform their work due to illness caused by the pandemic or local, state or federal orders requiring employees to remain at home; limitations on the ability of carriers to deliver products to customers; limitations on the ability of our customers to conduct their business and purchase our products and services; and limitations on the ability of our customers to pay us on a timely basis.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds.

 

None.

 

Item 

Item3.Defaults Upon Senior Securities.

Defaults Upon Senior Securities.

 

None.

 

Item 

Item4.Mine Safety Disclosures.

Mine Safety Disclosures.

 

Not Applicable.

 

Item 

Item5.Other Information.

Other Information.

 

None.

 

Item 6.

Item6.Exhibits.  

 

31.13.1

Certificate of Amendment to Amended Certificate of Incorporation. Incorporated by reference to Exhibit 3.1 to Current Report on Form 8-K filed on March 19, 2021. 

10.1

First Amendment to the Genasys Inc. Amended and Restated 2015 Equity Incentive Plan. Incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed on March 19, 2021.  

10.2

Loan Agreement, by and between Genasys Inc. and MUFG Union Bank, N.A. Incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed on March 17, 2021.  

10.3

Commercial Promissory Note, of Genasys Inc. in favor of MUFG Union Bank, N.A. Incorporated by reference to Exhibit 10.2 to Current Report on Form 8-K filed on March 17, 2021. 

10.4

Security Agreement, by and between the Company and MUFG Union Bank, N.A. Incorporated by reference to Exhibit 10.3 to Current Report on Form 8-K filed on March 17, 2021.  

31.1

Certification of Richard S. Danforth, Principal Executive Officer, pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

31.2

Certification of Dennis D. Klahn, Principal Financial Officer, pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

32.1

Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by Richard S. Danforth, Principal Executive Officer and Dennis D. Klahn, Principal Financial Officer.*

101.INS

XBRL Instance Document*

101.SCH

XBRL Taxonomy Extension Schema Document*

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document*

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document*

101.LAB

XBRL Taxonomy Extension Label Linkbase Document*

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document*

 


*          Filed concurrently herewith

Filed concurrently herewith.

 

32


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

GENASYS INC.

   

Date: August 10, 2020May 13, 2021

By: 

/s/    Dennis D. Klahn

Dennis D. Klahn,ChiefFinancialOfficer

(Principal Financial Officer)

 

3335